<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Non pharmacological interventions for spasticity in multiple sclerosis - Amatya, B - 2013 | Cochrane Library</title> <meta content="Non pharmacological interventions for spasticity in multiple sclerosis - Amatya, B - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009974.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Non pharmacological interventions for spasticity in multiple sclerosis - Amatya, B - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009974.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009974.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Non pharmacological interventions for spasticity in multiple sclerosis" name="citation_title"/> <meta content="Bhasker Amatya" name="citation_author"/> <meta content="Royal Melbourne Hospital, Royal Park Campus" name="citation_author_institution"/> <meta content="Bhasker.Amatya@mh.org.au" name="citation_author_email"/> <meta content="Fary Khan" name="citation_author"/> <meta content="Loredana La Mantia" name="citation_author"/> <meta content="I.R.C.C.S. Santa Maria Nascente Fondazione Don Gnocchi" name="citation_author_institution"/> <meta content="Marina Demetrios" name="citation_author"/> <meta content="Royal Melbourne Hospital, Royal Park Campus" name="citation_author_institution"/> <meta content="Derick T Wade" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD009974.pub2" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/02/28" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009974.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009974.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009974.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Exercise Therapy [methods]; Magnetic Field Therapy [methods]; Multiple Sclerosis [*complications]; Muscle Spasticity [etiology, *therapy]; Randomized Controlled Trials as Topic; Transcranial Magnetic Stimulation [methods]; Transcutaneous Electric Nerve Stimulation [methods]; Vibration [therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009974.pub2&amp;doi=10.1002/14651858.CD009974.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="xNbeAU8n";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009974\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009974\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009974\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009974\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009974.pub2",title:"Non pharmacological interventions for spasticity in multiple sclerosis",firstPublishedDate:"Feb 28, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xNbeAU8n&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009974.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009974.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009974.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009974.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009974.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009974.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009974.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009974.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009974.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009974.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>9590 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009974.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009974.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009974.pub2/full#CD009974-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009974.pub2/full#CD009974-sec-0078"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009974.pub2/full#CD009974-sec-0022"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009974.pub2/full#CD009974-sec-0030"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009974.pub2/full#CD009974-sec-0031"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009974.pub2/full#CD009974-sec-0055"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009974.pub2/full#CD009974-sec-0072"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009974.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009974.pub2/appendices#CD009974-sec-0082"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009974.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009974.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009974.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009974.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009974.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009974.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009974.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Non pharmacological interventions for spasticity in multiple sclerosis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009974.pub2/information#CD009974-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Bhasker Amatya</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009974.pub2/information#CD009974-cr-0003">Fary Khan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009974.pub2/information#CD009974-cr-0004">Loredana La Mantia</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009974.pub2/information#CD009974-cr-0005">Marina Demetrios</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009974.pub2/information#CD009974-cr-0006">Derick T Wade</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/information/en#CD009974-sec-0086">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 28 February 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009974.pub2">https://doi.org/10.1002/14651858.CD009974.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009974-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009974-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009974-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009974-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009974-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009974-abs-0001" lang="en"> <section id="CD009974-sec-0001"> <h3 class="title" id="CD009974-sec-0001">Background</h3> <p>Spasticity is commonly experienced by people with multiple sclerosis (MS), and it contributes to overall disability in this population. A wide range of non pharmacological interventions are used in isolation or with pharmacological agents to treat spasticity in MS. Evidence for their effectiveness is yet to be determined.  </p> </section> <section id="CD009974-sec-0002"> <h3 class="title" id="CD009974-sec-0002">Objectives</h3> <p>To assess the effectiveness of various non pharmacological interventions for the treatment of spasticity in adults with MS. </p> </section> <section id="CD009974-sec-0003"> <h3 class="title" id="CD009974-sec-0003">Search methods</h3> <p>A literature search was performed using the Specialised Register of the Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Review Group on using the Cochrane MS Group Trials Register which among other sources, contains CENTRAL, Medline, EMBASE, CINAHL, LILACS, PEDRO in June 2012. Manual searching in the relevant journals and screening of the reference lists of identified studies and reviews were carried out. Abstracts published in proceedings of conferences were also scrutinised. </p> </section> <section id="CD009974-sec-0004"> <h3 class="title" id="CD009974-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) that reported non pharmacological intervention/s for treatment of spasticity in adults with MS and compared them with some form of control intervention (such as sham/placebo interventions or lower level or different types of intervention, minimal intervention, waiting list controls or no treatment; interventions given in different settings), were included. </p> </section> <section id="CD009974-sec-0005"> <h3 class="title" id="CD009974-sec-0005">Data collection and analysis</h3> <p>Three review authors independently selected the studies, extracted data and assessed the methodological quality of the studies using the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) tool for best‐evidence synthesis. A meta‐analysis was not possible due to methodological, clinical and statistical heterogeneity of included studies. </p> </section> <section id="CD009974-sec-0006"> <h3 class="title" id="CD009974-sec-0006">Main results</h3> <p>Nine RCTs (N = 341 participants, 301 included in analyses) investigated various types and intensities of non pharmacological interventions for treating spasticity in adults with MS. These interventions included: physical activity programmes (such as physiotherapy, structured exercise programme, sports climbing); transcranial magnetic stimulation (Intermittent Theta Burst Stimulation (iTBS), Repetitive Transcranial Magnetic Stimulation (rTMS)); electromagnetic therapy (pulsed electromagnetic therapy; magnetic pulsing device), Transcutaneous Electrical Nerve Stimulation (TENS); and Whole Body Vibration (WBV). All studies scored 'low' on the methodological quality assessment implying high risk of bias.  </p> <p>There is 'low level' evidence for physical activity programmes used in isolation or in combination with other interventions (pharmacological or non pharmacological), and for repetitive magnetic stimulation (iTBS/rTMS) with or without adjuvant exercise therapy in improving spasticity in adults with MS. No evidence of benefit exists to support the use of TENS, sports climbing and vibration therapy for treating spasticity in this population. </p> </section> <section id="CD009974-sec-0007"> <h3 class="title" id="CD009974-sec-0007">Authors' conclusions</h3> <p>There is 'low level' evidence for non pharmacological interventions such as physical activities given in conjunction with other interventions, and for magnetic stimulation and electromagnetic therapies for beneficial effects on spasticity outcomes in people with MS. A wide range of non pharmacological interventions are used for the treatment of spasticity in MS, but more robust trials are needed to build evidence about these interventions. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009974-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009974-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD009974-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD009974-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009974-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009974-abs-0006">Français</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009974-abs-0004" lang="en"> <h3>Non pharmacological interventions for treatment of spasticity in Multiple Sclerosis (MS) </h3> <p>Spasticity is a common and debilitating symptom, causing ‘stiffness’, ‘spasms’ or ‘tightness’ in the weakened arm or leg in people with multiple sclerosis (MS). Overall, spasticity is difficult to treat. Current treatments include various medications (such as botulinum toxin injections to relax the affected muscles) and non drug methods aiming to achieve functional goals for patients (and their caregivers) such as physiotherapy, magnetic stimulation, electromagnetic therapy, vibration therapy. In this review, nine studies evaluating various non drug treatments to treat spasticity in adult with MS were included, comprising a total of 341 participants. Results from these studies suggest that all included non pharmacological therapies have low level of evidence or no evidence in improving spasticity in people with MS. However, caution should be used in the interpretation of the results, due to the poor methodological quality of all the included studies. More research is needed to determine the usefulness of these interventions before they can be recommended as routine treatments. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009974-sec-0078" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009974-sec-0078"></div> <h3 class="title" id="CD009974-sec-0079">Implications for practice</h3> <section id="CD009974-sec-0079"> <p>A range of non pharmacological interventions are used for the treatment of spasticity in people with MS. This review found only 'low level' evidence that physical activity given in conjunction with other interventions (such as BoNT, iTBS), magnetic stimulation and electromagnetic therapies have some beneficial effects on spasticity. Despite this, the evidence is inadequate for routine use of these treatments for treating spasticity in the MS population. </p> <p>Clinician involvement is needed to build evidence in spasticity outcomes from everyday clinical practice. The clinical applicability of findings of this review need to be confirmed in future well‐designed trials with bigger sample size and with longer‐term follow‐up. </p> </section> <h3 class="title" id="CD009974-sec-0080">Implications for research</h3> <section id="CD009974-sec-0080"> <p>In light of the review limitation mentioned above, future trials would need to consider the following. </p> <p> <ul id="CD009974-list-0038"> <li> <p>Robust studies with low bias, appropriate sample sizes and power to detect expected differences.                          </p> </li> <li> <p>Careful definition and selection of target patients.</p> </li> <li> <p>Longer follow‐up (more than six months) to determine benefits of an intervention.     </p> </li> <li> <p>Details of spasticity, localisation pattern, severity and impact on everyday function.                </p> </li> <li> <p>Use of appropriate, responsive outcome measures for spasticity that focus on activity limitation and ‘active/passive’ functional improvement, and achievement of individual goals of treatment.                          </p> </li> <li> <p>Demonstration of any differential treatment effect between single intensive interventions and multidisciplinary intervention. </p> </li> <li> <p>Appropriate intervention protocol for therapy (such as dose/intensity and time).                           </p> </li> <li> <p>Any adverse effects associated with the intervention.                        </p> </li> <li> <p>Caregiver burden and their involvement in the programmes.</p> </li> <li> <p>Cost‐utility of intervention                     </p> </li> </ul> </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009974-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009974-sec-0022"></div> <p>Multiple sclerosis (MS) is a chronic neurological disease characterised by patchy inflammation, gliosis and demyelination within the central nervous system (CNS). It affects approximately 2.5 million people worldwide (<a href="./references#CD009974-bbs2-0080" title="World Health Organization. Atlas: country resources for neurological disorders. Programme for Neurological Diseases and Neuroscience, Geneva2004. ">WHO 2004</a>). The patterns of presentation in MS can vary. These include: ‘relapsing remitting’ MS (80%), characterised by exacerbations and remission, which may convert to a ‘secondary progressive’ form of MS with progressive disability acquired between attacks; ‘primary progressive’ MS (15%), where persons develop progressive disability from the onset; and ‘progressive relapsing’ MS (5%), where persons begin worsening gradually and subsequently start to experience discrete attacks. People with MS have a prolonged median survival time from the time of diagnosis (approximately 40 years) (<a href="./references#CD009974-bbs2-0078" title="WeinshenkerBG , BassB , RiceGP , NoseworthyJ , CarriereW , BaskervilleJ , et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain1989;112:133‐46. ">Weinshenker 1989</a>). Therefore, issues of progressive physical disability, psychosocial adjustment and social reintegration progress over time and have implications for the person with MS, their carers and treating clinicians in terms of healthcare access, provision of services and financial burden. </p> <p>The clinical manifestations of MS are variable and can involve visual loss, double vision, motor weakness, spasticity, ataxia, tremor, sensory loss, sphincter dysfunction and cognitive impairment. People with MS can present with various combinations of deficits such as physical (weakness, spasticity, sensory loss and ataxia), cognitive (memory), psychosocial, behavioural and environmental problems which limit activity and participation. Spasticity is a common physical symptom experienced by almost two‐thirds of MS patients (<a href="./references#CD009974-bbs2-0066" title="RizzoMA , HadjimichaelOC , PreiningerovaJ , VollmerTL . Prevalence and treatment of spasticity reported by multiple sclerosis patients. Multiple Sclerosis2004;10:589‐95. ">Rizzo 2004</a>). Unlike static conditions (single episode of stroke and spinal cord injury), MS can have a fluctuating and often progressive course, making spasticity management more challenging. </p> <section id="CD009974-sec-0023"> <h3 class="title" id="CD009974-sec-0023">Description of the condition</h3> <section id="CD009974-sec-0024"> <h4 class="title">Spasticity in MS</h4> <p>Spasticity is a common phenomenon in patients with upper motor neuron (UMN) disorders including MS. The pathophysiology of spasticity is complex and not fully understood. Spasticity has traditionally been defined as 'a motor disorder which is a component of the UMN syndrome, characterised by a velocity‐dependent increase in tonic stretch reflexes (muscle tone) with exaggerated tendon jerks, resulting from hyperexcitability of the stretch reflex' (<a href="./references#CD009974-bbs2-0043" title="LanceJW . Spasticity: disordered motor control. In: FeldmanRG , YoungRR , KoellaWP editor(s). Symposium Synopsis. Chicago: Year Book Medical Publishers, 1980:485‐94. ">Lance 1980</a>). Another broader definition of spasticity is 'a disordered sensori‐motor control, resulting from an UMN lesion, presenting as intermittent or sustained involuntary activation of muscles' (<a href="./references#CD009974-bbs2-0056" title="PandyanAD , GregoricM , BarnesMP , WoodD , VanWijckF , BurridgeJ , et al. Spasticity: clinical perceptions, neurological realities and meaningful measurement. Disability and Rehabilitation2005;27(1‐2):2‐6. ">Pandyan 2005</a>). This definition suggests that 'spasticity’ can be interpreted as an umbrella term for an array of positive features of the UMN syndrome (<a href="./references#CD009974-bbs2-0052" title="MonaghanK , HorganF , BlakeC , CornallC , HickeyPPM , LyonsBE , et al. Physical treatment interventions for managing spasticity after stroke. Cochrane Database of Systematic Reviews2011, Issue 7. [DOI: 10.1002/14651858.CD009188] ">Monaghan 2011</a>). The key feature of spasticity is hyperexcitability of muscle stretch reflexes (<a href="./references#CD009974-bbs2-0021" title="AnsariNN , NaghdiS , HassonS , FakhariZ , MashayekhiM , HerasiM . Assessing the reliability of the Modified Modified Ashworth Scale between two physiotherapists in adult patients with hemiplegia. NeuroRehabilitation2009;25(4):235‐40. ">Ansari 2009</a>) due to an imbalance between excitatory and inhibitory spinal and supraspinal neuronal circuitries (<a href="./references#CD009974-bbs2-0054" title="MukherjeeA , ChakravartyA . Spasticity mechanisms – for the clinician. Frontiers in Neurology2010;149:1‐9. ">Mukherjee 2010</a>). Spasticity in MS is believed to be due to axonal degeneration or demyelination within specific descending tracts, or both, which leads to a disturbance of inhibitory interneuronal spinal network pathways. </p> <p>MS‐related spasticity may be generalised, focal (affecting a localised part of a limb) or multifocal (affecting more than one part of a limb or limbs). Spasticity results in stiffness and abnormal posturing of the limb due to net imbalance of forces between the agonist and antagonist muscles, affecting static joint position and dynamic limb movement (<a href="./references#CD009974-bbs2-0069" title="SheeanG . Pathophysiology of spasticity. In: SheeanG editor(s). Spasticity Rehabilitation. First Edition. London: Churchill Communications Europe LTD, 1998:17‐38. ">Sheean 1998</a>). It may also affect the truncal musculature resulting in poor postural control. Spasticity has a direct correlation with disease progression, and resulting weakness and fatigability (negative features of the UMN syndrome), which often contribute to patient problems. Further, adaptive features may develop, including contractures and rheological changes in muscle, tendons and joints (<a href="./references#CD009974-bbs2-0055" title="O'DwyerNJ , AdaL . Reflex hyperexcitability and muscle contracture in relation to spastic hypertonia. Current Opinion in Neurology1996;9(6):451‐5. ">O'Dwyer 1996</a>), which can further exacerbate limb positioning, movement and function. The effect of muscle overactivity, weakness and soft tissue contractures on patient function should be assessed in order to ensure appropriate management. </p> </section> <section id="CD009974-sec-0025"> <h4 class="title">Spasticity‐related problems</h4> <p>It is estimated that 60% to 90% of people with MS develop spasticity during their lifetime (<a href="./references#CD009974-bbs2-0066" title="RizzoMA , HadjimichaelOC , PreiningerovaJ , VollmerTL . Prevalence and treatment of spasticity reported by multiple sclerosis patients. Multiple Sclerosis2004;10:589‐95. ">Rizzo 2004</a>), and it is a major contributor to overall disability (<a href="./references#CD009974-bbs2-0024" title="BeardS , HunnA , WightJ . Treatments for spasticity and pain in multiple sclerosis: a systematic review. Health Technology Assessment2003;7:1‐111. ">Beard 2003</a>). In some instances, spasticity may be beneficial by counteracting muscle weakness, thereby increasing stability of the lower limb/s (<a href="./references#CD009974-bbs2-0036" title="HenzeT , RieckmannP , ToykaKV . Symptomatic treatment of multiple sclerosis (Multiple Sclerosis Therapy Consensus Group (MSTCG) of the German Multiple Sclerosis Society). European Neurology2006;56:78–105. ">Henze 2006</a>). However, spasticity should be treated when it interferes with activity or the ability to provide care to the person with MS, such as hand hygiene. Inadequate treatment may result in pain, contractures and pressure sores, which may further impact on function (<a href="./references#CD009974-bbs2-0024" title="BeardS , HunnA , WightJ . Treatments for spasticity and pain in multiple sclerosis: a systematic review. Health Technology Assessment2003;7:1‐111. ">Beard 2003</a>; <a href="./references#CD009974-bbs2-0066" title="RizzoMA , HadjimichaelOC , PreiningerovaJ , VollmerTL . Prevalence and treatment of spasticity reported by multiple sclerosis patients. Multiple Sclerosis2004;10:589‐95. ">Rizzo 2004</a>). </p> <p>Spasticity‐associated problems can be classified according to the World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) (<a href="./references#CD009974-bbs2-0079" title="World Health Organization. International Classification of Functioning Disability and Health (ICF). Geneva: WHO2001. ">WHO 2001</a>) ‐ a framework used to describe the impact of disease at different levels. Spasticity‐related problems in people with MS may include: </p> <p> <ul id="CD009974-list-0001"> <li> <p>impairments (problems with body structures or physiological function) such as restricted joint range of movement, loss of dexterity, abnormal limb postures and pain; </p> </li> <li> <p>activity limitations including: (i) limitation in active limb use by the patient ('active' function) which can interfere with mobility and transfers, and independence with activities of daily living (ADL) such as feeding, grooming and bathing; (ii) difficulty with provision of care to an affected limb by the person with MS or their carer ('passive' function’), such as maintaining palmar hygiene or applying a splint or orthotic; </p> </li> <li> <p>restrictions in ‘participation’ limiting societal roles relating to family, work and life situations. </p> </li> </ul> </p> <p>In addition to spasticity and the broader effects of the UMN syndrome described above, other MS‐related problems, such as fatigue, cognitive, psychosocial, behavioural and environmental issues, can contribute to overall disability. Furthermore, issues of impairment, activity limitation and restriction in participation progress over time (<a href="./references#CD009974-bbs2-0040" title="KhanF , Turner‐StokesL , NgL , KilpatrickT , AmatyaB . Multidisciplinary rehabilitation for adults with multiple sclerosis. Cochrane Database of Systematic Reviews2007, Issue 2. [DOI: 10.1002/14651858.CD006036] ">Khan 2007</a>; <a href="./references#CD009974-bbs2-0041" title="KhanF , GrayO . Disability management and rehabilitation for persons with multiple sclerosis. Neural Regeneration Research2010;5(4):301‐9. ">Khan 2010</a>) and are compounded by age‐related issues. Thus, management is complex requiring multiple treatment approaches (<a href="./references#CD009974-bbs2-0058" title="PflegerCC , FlachsEM , Koch‐HenriksenN . Social consequences of multiple sclerosis (1): early pension and temporary unemployment‐‐a historical prospective cohort study. Multiple Sclerosis2010;16:121‐6. ">Pfleger 2010</a>; <a href="./references#CD009974-bbs2-0059" title="PflegerCC , FlachsEM , Koch‐HenriksenN . Social consequences of multiple sclerosis. Part 2. Divorce and separation: a historical prospective cohort study. Multiple Sclerosis2010;16:878‐82. ">Pfleger 2010a</a>). Understanding the many challenges faced by people with MS, and spasticity in particular, can have considerable impact due to the increased demand for health care. </p> </section> <section id="CD009974-sec-0026"> <h4 class="title">Spasticity management</h4> <p>The key to spasticity management is achievement of individualised, patient‐centred goals that are set collaboratively with patients, their carers and rehabilitation team in a functional context. Goals may be focused on reducing symptoms or impairments, or improving activity level (active and passive function), participation and quality of life (QOL). Elimination or avoidance of triggers which may initiate or enhance spasticity (such as urogenital infections, constipation, pain) and prevention of complications (such as contractures and pressure sores) may also be important (<a href="./references#CD009974-bbs2-0036" title="HenzeT , RieckmannP , ToykaKV . Symptomatic treatment of multiple sclerosis (Multiple Sclerosis Therapy Consensus Group (MSTCG) of the German Multiple Sclerosis Society). European Neurology2006;56:78–105. ">Henze 2006</a>; <a href="./references#CD009974-bbs2-0063" title="RekandT . Clinical assessment and management of spasticity: a review. Acta Neurologica Scandinavica2010;190:62‐6. ">Rekand 2010</a>).  </p> <p>Non pharmacological interventions used in isolation and/or pharmacological agents are the mainstay in the management of spasticity, and rarely is there a place for surgical intervention (<a href="./references#CD009974-bbs2-0071" title="StevensonVL . Spasticity management. Clinical Rehabilitation2010;24:293‐304. ">Stevenson 2010</a>). Pharmacological treatments may include antispasmodic medications such as baclofen, diazepam, dantrolene and tizanidine (<a href="./references#CD009974-bbs2-0024" title="BeardS , HunnA , WightJ . Treatments for spasticity and pain in multiple sclerosis: a systematic review. Health Technology Assessment2003;7:1‐111. ">Beard 2003</a>; <a href="./references#CD009974-bbs2-0068" title="ShakespeareD , BoggildM , YoungCA . Anti‐spasticity agents for multiple sclerosis. Cochrane Database of Systematic Reviews2003, Issue 4. [DOI: 10.1002/14651858.CD001332] ">Shakespeare 2003</a>; <a href="./references#CD009974-bbs2-0071" title="StevensonVL . Spasticity management. Clinical Rehabilitation2010;24:293‐304. ">Stevenson 2010</a>). They have limited effectiveness and are associated with various systemic side effects, such as drowsiness, cognitive impairment and muscle weakness. Other treatments, such as intrathecal baclofen via a programmable implanted pump (<a href="./references#CD009974-bbs2-0034" title="HarnedME , SallesSS , GriderJS . An introduction to trialing intrathecal baclofen in patients with hemiparetic spasticity: a description of 3 cases. Pain Physician2011;14(5):483‐9. ">Harned 2011</a>), are invasive and substantially more expensive. Their use is usually restricted to people with severe disabling spasticity (<a href="./references#CD009974-bbs2-0024" title="BeardS , HunnA , WightJ . Treatments for spasticity and pain in multiple sclerosis: a systematic review. Health Technology Assessment2003;7:1‐111. ">Beard 2003</a>; <a href="./references#CD009974-bbs2-0036" title="HenzeT , RieckmannP , ToykaKV . Symptomatic treatment of multiple sclerosis (Multiple Sclerosis Therapy Consensus Group (MSTCG) of the German Multiple Sclerosis Society). European Neurology2006;56:78–105. ">Henze 2006</a>). Botulinum toxin A (BoNT) has been favoured as the pharmacological treatment of choice for the management of focal spasticity not responding to non pharmacological therapy (<a href="./references#CD009974-bbs2-0029" title="DePaivaA , MeuniereFA , MolgoJ , AokiKR , DollyJO . Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proceedings of the National Academy of Sciences, United States of America. 1999; Vol. 16, issue 96:3200‐5. ">De Paiva 1999</a>). </p> <p>A wide range of non pharmacological interventions for spasticity management are currently used, including: physical interventions, therapeutic ultrasound, electromagnetic therapies, acupuncture and orthotics (splints, garments). Often treatments are used in combination, encompassing a multidisciplinary rehabilitation approach. </p> </section> </section> <section id="CD009974-sec-0027"> <h3 class="title" id="CD009974-sec-0027">Description of the intervention</h3> <p>In this review all non pharmacological interventions for spasticity in people with MS were included, which included: </p> <p> <ul id="CD009974-list-0002"> <li> <p>uni‐disciplinary therapy, e.g. physiotherapy or occupational therapy only; </p> </li> <li> <p>individual non pharmacological treatment modalities or physical interventions that may form a component of a rehabilitation programme (described below); </p> </li> <li> <p>multidisciplinary rehabilitation programmes involving the provision of a co‐ordinated programme by a specialised team of health professionals, delivered by two or more disciplines (medical, nursing, physiotherapy, occupational therapy, orthotists and others), primarily aimed at reducing spasticity. </p> </li> </ul> </p> <p>The usual elements of a multidisciplinary rehabilitation programme are (<a href="./references#CD009974-bbs2-0070" title="SteinsS , O'YoungB , YoungM . Person‐centred rehabilitation: interdisciplinary intervention to enhance patient enablement. In: O'YoungB , YoungM , SteinsS editor(s). Physical Medicine and Rehabilitation Secrets. United States of America: Hanley &amp; Belfus, 2002:4‐9. ">Steins 2002</a>): </p> <p> <ul id="CD009974-list-0003"> <li> <p>an individualised, patient‐centred plan formulated by the patient and rehabilitation team; </p> </li> <li> <p>goals derived and prioritised through a multidisciplinary process, where goals are specific, measurable, achievable, realistic and timely (<a href="./references#CD009974-bbs2-0077" title="WadeDT , Bovend’EerdtTJH . How to set SMART goals. Clinical Rehabilitation2010;24(4):382. ">Wade 2010</a>); </p> </li> <li> <p>patient participation required to achieve the goals with improvement in the patient’s personal potential as a result; </p> </li> <li> <p>outcomes demonstrating improvement in one or more domains of the ICF.</p> </li> </ul> </p> <p>Individual treatment modalities or physical interventions used in uni‐disciplinary or multidisciplinary rehabilitation settings may include (but are not limited to): stretching; neurodevelopmental treatment; static positioning; orthotics (splints, garments); casting; strengthening exercises; Transcutaneous Electric Nerve Stimulation (TENS); hydrotherapy; thermotherapy (infra‐red heat); cryotherapy (cold); shock waves; vibratory stimulation (whole‐body vibration); electromyography (EMG) biofeedback; Repetitive Transcranial Magnetic Stimulation (rTMS); therapeutic ultrasound; continuous passive motion robotics; acupuncture; psychological and educational interventions. </p> </section> <section id="CD009974-sec-0028"> <h3 class="title" id="CD009974-sec-0028">How the intervention might work</h3> <p>Physical interventions for the treatment of spasticity are thought to have some beneficial effects (<a href="./references#CD009974-bbs2-0045" title="LockleyLJ , BuchananK . Physical management of spasticity. In: StevensonVL , JarrettL editor(s). Spasticity Management: a Practical Multidisciplinary Guide. London: Informa Healthcare, 2006:37‐58. ">Lockley 2006</a>; <a href="./references#CD009974-bbs2-0071" title="StevensonVL . Spasticity management. Clinical Rehabilitation2010;24:293‐304. ">Stevenson 2010</a>) and are assumed to have some or all of the following effects (<a href="./references#CD009974-bbs2-0045" title="LockleyLJ , BuchananK . Physical management of spasticity. In: StevensonVL , JarrettL editor(s). Spasticity Management: a Practical Multidisciplinary Guide. London: Informa Healthcare, 2006:37‐58. ">Lockley 2006</a>): </p> <p> <ul id="CD009974-list-0004"> <li> <p>minimising changes in the viscoelastic properties of the connective tissue;</p> </li> <li> <p>altering the neural patterns of spasticity or spasms;</p> </li> <li> <p>maintaining levels of function for the individual.</p> </li> </ul> </p> <p>Some non pharmacological interventions for spasticity have been studied: e.g. repetitive training of isolated movements was found to reduce spasticity in a paretic hand (<a href="./references#CD009974-bbs2-0028" title="BuetefischC , HummelsheimH , DenzlerP , MauritzKH . Repetitive training of isolated movements improves the outcome of motor rehabilitation of the centrally paretic hand. Journal of Neurological Sciences1995;130:59–68. ">Buetefisch 1995</a>); cryotherapy (cooling) (<a href="./references#CD009974-bbs2-0050" title="MecomberSA , HermanRM . Effects of local hypothermia on reflex and voluntary activity. Physical Therapy1971;51(3):271‐81. ">Mecomber 1971</a>) and hydrotherapy (<a href="./references#CD009974-bbs2-0039" title="KesiktasN , PakerN , ErdoganN , GülsenG , BiçkiD , YilmazH . The use of hydrotherapy for the management of spasticity. Neurorehabilitation and Neural Repair2004;18(4):268‐73. ">Kesiktas 2004</a>) were reported to exhibit a transient beneficial effect on elevated muscle tone; hydrotherapy has been suggested to reduce spasticity and the need for baclofen in patients with spinal cord injury (<a href="./references#CD009974-bbs2-0039" title="KesiktasN , PakerN , ErdoganN , GülsenG , BiçkiD , YilmazH . The use of hydrotherapy for the management of spasticity. Neurorehabilitation and Neural Repair2004;18(4):268‐73. ">Kesiktas 2004</a>). On the other hand, TENS and vibration stimulation (whole‐body vibration) may have no additional benefit for spasticity in people with MS (<a href="./references#CD009974-bbs2-0003" title="MillerL , MattisonP , PaulL , WoodL . The effects of Transcutaneous Electrical Nerve Stimulation (TENS) on spasticity in Multiple Sclerosis. Multiple Sclerosis2007;13:527‐33. ">Miller 2007</a>; <a href="./references#CD009974-bbs2-0008" title="SchynsF , PaulL , FinlayK , FergusonC , NobleE . Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clinical Rehabilitation2009;23(9):771‐81. ">Schyns 2009</a>). </p> <p>The effectiveness of pharmacological treatments which include antispasmodic medications such as baclofen, diazepam, dantrolene and tizanidine and BoNT have been explored (<a href="./references#CD009974-bbs2-0024" title="BeardS , HunnA , WightJ . Treatments for spasticity and pain in multiple sclerosis: a systematic review. Health Technology Assessment2003;7:1‐111. ">Beard 2003</a>; <a href="./references#CD009974-bbs2-0029" title="DePaivaA , MeuniereFA , MolgoJ , AokiKR , DollyJO . Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proceedings of the National Academy of Sciences, United States of America. 1999; Vol. 16, issue 96:3200‐5. ">De Paiva 1999</a>; <a href="./references#CD009974-bbs2-0068" title="ShakespeareD , BoggildM , YoungCA . Anti‐spasticity agents for multiple sclerosis. Cochrane Database of Systematic Reviews2003, Issue 4. [DOI: 10.1002/14651858.CD001332] ">Shakespeare 2003</a>; <a href="./references#CD009974-bbs2-0071" title="StevensonVL . Spasticity management. Clinical Rehabilitation2010;24:293‐304. ">Stevenson 2010</a>). Overall effectiveness of multidisciplinary rehabilitation interventions in neurological conditions such as MS (<a href="./references#CD009974-bbs2-0040" title="KhanF , Turner‐StokesL , NgL , KilpatrickT , AmatyaB . Multidisciplinary rehabilitation for adults with multiple sclerosis. Cochrane Database of Systematic Reviews2007, Issue 2. [DOI: 10.1002/14651858.CD006036] ">Khan 2007</a>), acquired brain injury (<a href="./references#CD009974-bbs2-0072" title="Turner‐StokesL , NairA , SedkiI , DislerPB , WadeDT . Multi‐disciplinary rehabilitation for acquired brain injury in adults of working age. Cochrane Database of Systematic Reviews2011, Issue 1. [DOI: 10.1002/14651858.CD004170.pub2] ">Turner‐Stokes 2011</a>) and stroke (<a href="./references#CD009974-bbs2-0044" title="LanghorneP , BernhardtJ , KwakkelG . Stroke rehabilitation. Lancet2011;377(9778):1693‐702. ">Langhorne 2011</a>) have been documented. There are, however, no systematic reviews to highlight the effectiveness of non pharmacological interventions (uni‐disciplinary, multidisciplinary or both) for spasticity management in people with MS.  Although recent guidelines and consensus statements on spasticity management advocate various non pharmacological approaches (<a href="./references#CD009974-bbs2-0035" title="HaselkornJk , LittleJW , Balsdon RicherCB , MillerJR , Fry‐WelchD , HerndonRM , et al. Spasticity management in Multiple Sclerosis. Journal of Spinal Cord Medicine2005;28(2):167‐99. ">Haselkorn 2005</a>; <a href="./references#CD009974-bbs2-0053" title="MSAustralia . Spasticity and multiple sclerosis. MS Practice:June 2009; Vol. ISBN: 978‐0‐9806637‐4‐7. ">MS Australia 2009</a>), the evidence is based mostly on isolated studies, narrative reviews or expert opinions.   </p> </section> <section id="CD009974-sec-0029"> <h3 class="title" id="CD009974-sec-0029">Why it is important to do this review</h3> <p>Spasticity is a common and disabling phenomenon experienced by people with MS, which impacts on patients' function (mobility, ability for self‐care and everyday living activities, psychosocial life) and requires long‐term management. A wide range of non pharmacological interventions are currently being used to manage spasticity, but the benefit and harms associated with these interventions in people with MS have not been established. </p> <p>A systematic evaluation of the existing evidence is therefore required to guide treating clinicians in spasticity management.  </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009974-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009974-sec-0030"></div> <p>This review aimed to investigate the effectiveness and safety of non pharmacological interventions for the management of spasticity in people with MS in improving patient outcomes. </p> <p>Specific questions addressed by this review included the following.</p> <p> <ul id="CD009974-list-0005"> <li> <p>Are non pharmacological interventions (uni‐disciplinary and/or multidisciplinary rehabilitation) effective in minimising impairment, activity limitation and participation restriction in people with MS with spasticity? </p> </li> <li> <p>What non pharmacological interventions (uni‐disciplinary and/or multidisciplinary rehabilitation) are effective in reducing spasticity in people with MS, and in which setting? </p> </li> <li> <p>Are non pharmacological interventions (uni‐disciplinary and/or multidisciplinary rehabilitation) effective in minimising the burden of care and improving quality of life in people with MS with spasticity? </p> </li> </ul> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009974-sec-0031" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009974-sec-0031"></div> <section id="CD009974-sec-0032"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009974-sec-0033"> <h4 class="title">Types of studies</h4> <p>All randomised controlled trials (RCTs) that compared a non pharmacological therapy to treat spasticity in people with MS with a control situation were included (see <a href="#CD009974-sec-0035">Types of interventions</a> for detail on the control situations).   </p> </section> <section id="CD009974-sec-0034"> <h4 class="title">Types of participants</h4> <p>Adults (18 years or over) with MS and spasticity affecting upper or lower limbs or both, and generalised, focal or multifocal spasticity were included. All participants had a confirmed diagnosis of MS based on validated criteria (<a href="./references#CD009974-bbs2-0049" title="McDonaldWI , CompstonA , EdanG , GoodkinD , HartungHP , LublinFD , et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of Neurology2001;50(1):121‐7. ">Mc Donald 2001</a>; <a href="./references#CD009974-bbs2-0061" title='PolmanCH , ReingoldSC , EdanG , FilippiM , HartungHP , KapposL , et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Annals of Neurology2005;58(6):840‐6. '>Polman 2005</a>; <a href="./references#CD009974-bbs2-0062" title="PoserCM , PatyDW , ScheinbergL , McDonaldWI , DavisFA , EbersGC , et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Annals of Neurology1983;13(3):227‐31. ">Poser 1993</a>). All subgroups of the disease such as relapsing remitting, primary progressive and secondary progressive MS were included (<a href="./references#CD009974-bbs2-0046" title="LublinFD , ReingoldSC . Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology1996;46(4):907‐11. ">Lublin 1996</a>). </p> </section> <section id="CD009974-sec-0035"> <h4 class="title">Types of interventions</h4> <p>All modalities of non pharmacological interventions aimed at reducing spasticity in people with MS were considered; these included the following: </p> <p> <ul id="CD009974-list-0006"> <li> <p>uni‐disciplinary therapy, e.g. physiotherapy or occupational therapy only, and individual treatment modalities or physical activity programmes (as described in <a href="#CD009974-sec-0027">Description of the intervention</a>); </p> </li> <li> <p>multidisciplinary rehabilitation programmes. In this review, multidisciplinary rehabilitation is defined as any co‐ordinated therapy programme delivered by two or more disciplines (occupational therapy, physiotherapy, exercise physiology, orthotics, other allied health and nursing) in conjunction with medical input (neurologist or rehabilitation medicine physician) that aims to achieve patient‐centred goals related to reducing spasticity. </p> </li> </ul> </p> <p>The settings of rehabilitation programmes included the following:</p> <p> <ul id="CD009974-list-0007"> <li> <p>outpatient or day treatment settings, which were located within private or public hospitals, community rehabilitation centres or specialist rehabilitation centres; </p> </li> <li> <p>home‐based settings, in the patients' own homes and local community;</p> </li> <li> <p>inpatient rehabilitation settings where care was delivered 24 hours per day, including specialised medical rehabilitation units or hospital wards. </p> </li> </ul> </p> <p>Rehabilitation programmes and interventions are individualised, thus treatments provided can be variable and the actual content of rehabilitation care may vary from patient to patient. Therefore, we included any study that stated or implied rehabilitation provided it satisfied the definition as stated above and compared it to a control situation. </p> <p>Control situations included: no treatment; placebo/sham; and other interventions, for example, lower‐level or different types of intervention such as 'routinely available local services' (e.g. medical care or physiotherapy only), 'minimal intervention' (such as 'information only'), waiting list conditions, or interventions given in different settings (ambulatory, inpatient or home) and lower‐intensity or different variants of intervention (e.g. lower dosage/intensity, different mode of delivery). </p> <p>Concomitant pharmacological/surgical interventions were accepted, if administered in the same way in both the control and the treated groups. Surgical and pharmacological interventions provided in isolation for spasticity management were not considered in this review. </p> </section> <section id="CD009974-sec-0036"> <h4 class="title">Types of outcome measures</h4> <p>Diverse outcomes were identified, given the varied presentations of spasticity‐related problems and goals of treatment related to MS severity. </p> <section id="CD009974-sec-0037"> <h5 class="title">Primary outcomes</h5> <p>Primary outcomes reflected the level of activity limitation and impairment according to the ICF (<a href="./references#CD009974-bbs2-0079" title="World Health Organization. International Classification of Functioning Disability and Health (ICF). Geneva: WHO2001. ">WHO 2001</a>), which included the following: </p> <p> <ul id="CD009974-list-0008"> <li> <p>reduction in spasticity [e.g. the Ashworth (<a href="./references#CD009974-bbs2-0023" title="AshworthB . Preliminary trial of carisoprodol in multiple sclerosis. Practitioner1964;192:540‐2. ">Ashworth 1964</a>) or Modified Ashworth Scale (MAS) (<a href="./references#CD009974-bbs2-0026" title="BohannonRW , SmithMB . Interrater reliability of a modified Ashworth scale of muscle spasticity. Physical Therapy1987;67(2):206‐7. ">Bohannon 1987</a>; <a href="./references#CD009974-bbs2-0021" title="AnsariNN , NaghdiS , HassonS , FakhariZ , MashayekhiM , HerasiM . Assessing the reliability of the Modified Modified Ashworth Scale between two physiotherapists in adult patients with hemiplegia. NeuroRehabilitation2009;25(4):235‐40. ">Ansari 2009</a>)]; </p> </li> <li> <p>improvement in upper limb functioning and (upper limb‐related) ADL: passive function or ease of care [e.g. Leeds Arm Spasticity Impact Scale (<a href="./references#CD009974-bbs2-0025" title="BhaktaB , CoxensJ , BamfordJ , ChamberlainMA . Use of botulinum toxin in stroke patiens with severe upper limb spasticity. Journal of Neurology, Neurosurgery and Psychiatry1996;61:30‐5. ">Bhakta 1996</a>), Disability Assessment Scale (<a href="./references#CD009974-bbs2-0027" title="BrashearA , GordonM , ElovicE , KassiciehD , MarciniakC , LeeC , et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke. New England Journal of Medicine2002;347(6):395‐400. ">Brashear 2002</a>), Arm Activity measure (<a href="./references#CD009974-bbs2-0022" title="AshfordS , Turner‐StokesL , NairA . Poster 19: Psychometric evaluation of the Arm Activity Measure (ArmA) – A measure of active and passive function in the hemiparetic arm. Physical Medicine and Rehabilitation2010;2(9 Suppl):S13‐4. ">Ashford 2010</a>); active motor function [e.g. Motor Activity Log (MAL) (<a href="./references#CD009974-bbs2-0073" title="Van derLeeJH , BeckermanH , KnollDL , deVetHC , BouterLM . Clinimetric properties of the motor activity log for the assessment of arm use in hemiparetic patients. Stroke2004;35:1410‐4. ">Van der Lee 2004</a>) or Action Research Arm Test (ARAT) (<a href="./references#CD009974-bbs2-0047" title="LyleRC . A performance test for assessment of upper limb function in physical rehabilitation treatment and research. International Journal of Rehabilitation Research1981;4:483‐92. ">Lyle 1981</a>)]; </p> </li> <li> <p>improvement in mobility, including tests of walking speed, balance and gait pattern [e.g. Timed Up And Go (TUAG) (<a href="./references#CD009974-bbs2-0060" title="PodsiadloD , RichardsonS . The timed 'up and go': a test of basic functional mobility for frail elderly persons. Journal of the American Geriatrics Society1991;39:142‐8. ">Podsiadlo 1991</a>), Barthel index (BI) (<a href="./references#CD009974-bbs2-0048" title="MahoneyFI , BarthelD . Functional evaluation: the Barthel Index. Maryland State Medical Journal1965;14:56‐61. ">Mahoney 1965</a>), 10‐metre walk test (<a href="./references#CD009974-bbs2-0033" title="GreenJ , ForsterA . Reliability of gait speed measured by a timed walking test in patients one year after stroke. Clinical Rehabilitation2002;16:306‐14. ">Green 2002</a>)]; </p> </li> <li> <p>any adverse events that had resulted from the intervention. We defined serious adverse effects as those events that were life‐threatening or required prolonged hospitalisation.  </p> </li> </ul> </p> <p>The measures of achievement of intended goals for treatment (e.g. goal attainment scaling or other measure of goal achievement) were also included. The assimilation of individualised goals for treatment was increasingly used as an overall measure of outcome for trials of rehabilitation. Various outcomes measures were expected, hence specific outcome measures did not form part of the inclusion criteria for this review. </p> </section> <section id="CD009974-sec-0038"> <h5 class="title">Secondary outcomes</h5> <p>These included specific outcomes that reflect:</p> <p> <ul id="CD009974-list-0009"> <li> <p>symptoms or impairments, e.g. pain (measured by verbal scores, visual analogue scales), spasm frequency (Penn Spasm Frequency Scale (<a href="./references#CD009974-bbs2-0057" title="PennRD , SavoySM , CorcosD , LatashM , GottliebG , ParkeB , et al. Intrathecal baclofen for severe spasticity. New England Journal of Medicine1989;320(23):1517‐21. ">Penn 1989</a>), joint range of movement (using MAS (<a href="./references#CD009974-bbs2-0021" title="AnsariNN , NaghdiS , HassonS , FakhariZ , MashayekhiM , HerasiM . Assessing the reliability of the Modified Modified Ashworth Scale between two physiotherapists in adult patients with hemiplegia. NeuroRehabilitation2009;25(4):235‐40. ">Ansari 2009</a>; <a href="./references#CD009974-bbs2-0026" title="BohannonRW , SmithMB . Interrater reliability of a modified Ashworth scale of muscle spasticity. Physical Therapy1987;67(2):206‐7. ">Bohannon 1987</a>), Tardieu scale (<a href="./references#CD009974-bbs2-0020" title="AnsariNN , NaghdiS , HassonS , AzarsaMH , AzarniaS . The Modified Tardieu Scale for the measurement of elbow flexor spasticity in adult patients with hemiplegia. Brain Injury2008;22(13‐14):1007‐12. ">Ansari 2008</a>; <a href="./references#CD009974-bbs2-0051" title="MehrholzJ , WagnerK , MeissnerD , GrundmannK , ZangeC , KochR , et al. Reliability of the Modified Tardieu Scale and the Modified Ashworth Scale in adult patients with severe brain injury: a comparison study. Clinical Rehabilitation2005;19:751‐9. ">Mehrholz 2005</a>)), involuntary movements; </p> </li> <li> <p>restriction in participation and impact on carers: impact of spasticity in people with MS [e.g. Multiple Sclerosis Spasticity Scale (MSSS‐88); <a href="./references#CD009974-bbs2-0038" title="HobartJC , RiaziA , ThompsonAJ , StylesIM , IngramW , VickeryPJ , et al. Getting the measure of spasticity in multiple sclerosis: The Multiple Sclerosis Spasticity Scale (MSSS‐88). Brain2006;129:224‐34. ">Hobart 2006</a>), reduction of carer strain and burden (e.g. Caregiver Strain Index (CSI); (<a href="./references#CD009974-bbs2-0067" title="RobinsonBC . Validation of a Caregiver Strain Index (CSI). Journal of Gerontology1983;38(3):344‐8. ">Robinson 1983</a>), quality of life (e.g. MS Quality of Life (MSQOL 54); <a href="./references#CD009974-bbs2-0076" title="VickreyBG , HaysRD , GenoveseBJ , MyersLW , EllisonGW . Comparison of a generic to disease‐targeted health‐related quality‐of‐life measures for multiple sclerosis. Journal of Clinical Epidemiology1997;50(5):557‐69. ">Vickrey 1997</a>)]. </p> </li> <li> <p>outcomes that reflected service utilisation, including costs of care, length of hospital admissions, readmission and extent of use of services. </p> </li> </ul> </p> <section id="CD009974-sec-0039"> <h6 class="title">Timing of outcome measures</h6> <p>The outcome time points were either short‐term (up to three months) or long‐term (greater than three months) from the start of the intervention. </p> </section> </section> </section> </section> <section id="CD009974-sec-0040"> <h3 class="title">Search methods for identification of studies</h3> <p>We conducted a systematic search to identify all relevant published and unpublished RCTs. No language restrictions were applied to the search. </p> <section id="CD009974-sec-0041"> <h4 class="title">Electronic searches</h4> <p>The Trials Search Co‐ordinator searched the Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Working Group on using the Cochrane MS Group Trials Register (20 June 2012) which among other sources, contains CENTRAL, MEDLINE, EMBASE, CINAHL, LILACS, PEDRO. The search terms are listed in Appendix 1 (<a href="./appendices#CD009974-sec-0083">Appendix 1</a>). For the search strategy used to search the Cochrane Central Register of Controlled Trials (CENTRAL) please see: <a href="./appendices#CD009974-sec-0084">Appendix 2</a>. </p> <p>In addition, we searched the Clinical trials registries (<a href="http://clinicaltrials.gov/" target="_blank">http://clinicaltrials.gov</a>) and The WHO International Clinical Trials Registry Platform (ICTRP) search portal (<a href="http://apps.who.int/trialsearch/Default.aspx" target="_blank">http://apps.who.int/trialsearch/Default.aspx</a>) for all prospectively registered and ongoing trials. </p> <p>Information on the Specialised Register and details of search strategies used to identify trials can be found in the 'Specialised Register' section within the <a href="http://www.msg.cochrane.org" target="_blank">Multiple Sclerosis and Rare Diseases of the Central Nervous System Group</a> module. </p> </section> <section id="CD009974-sec-0042"> <h4 class="title">Searching other resources</h4> <p>An expanded search was performed to identify articles potentially missed through the database searches and articles from ‘grey literature' from 1996 to June 2012. This included: </p> <p> <ul id="CD009974-list-0010"> <li> <p>handsearches of reference lists of all retrieved articles, texts and other reviews on the topic; </p> </li> <li> <p>handsearches of the most relevant journals related to MS and spasticity research and treatment (such as, but not limited to: <i>Archives of Physical Medicine and Rehabilitation</i> ; <i>Journal of Rehabilitation Medicine</i> ; <i>Journal of Neurology</i> ; <i>Journal of Neurology, Neurosurgery and Psychiatry</i> , <i>Clinical Rehabilitation</i> , <i>Neurology</i> , <i>Physical Therapy</i> , <i>Multiple Sclerosis</i> and others); </p> </li> <li> <p>searches using the related articles feature (via PubMed);</p> </li> <li> <p>searches of ProQuest Dissertations and Theses;</p> </li> <li> <p>searches of Web of Science for citation of key authors;</p> </li> <li> <p>searches of SIGLE (System for Information on Grey Literature in Europe);</p> </li> <li> <p>contacting local and foreign experts for further information (such as the Cochrane MS Group, key authors of publications in this review); </p> </li> <li> <p>contacting authors and researchers active in this field.</p> </li> </ul> </p> <p>The following websites were also searched for ongoing and unpublished trials:</p> <p> <ul id="CD009974-list-0011"> <li> <p>Current Controlled Trials (<a href="http://www.controlled-trials.com" target="_blank">http://www.controlled‐trials.com</a>); </p> </li> <li> <p>UK Clinical Research Network Portfolio Database (<a href="http://public.ukcrn.org.uk/search/" target="_blank">http://public.ukcrn.org.uk/search/</a>). </p> </li> </ul> </p> </section> </section> <section id="CD009974-sec-0043"> <h3 class="title" id="CD009974-sec-0043">Data collection and analysis</h3> <section id="CD009974-sec-0044"> <h4 class="title">Selection of studies</h4> <p>Two review authors (BA, LLM) independently screened and short listed all abstracts and titles of studies identified by the search strategy for appropriateness based on the selection criteria. The review authors (BA, FK, LLM) independently evaluated each study from the shortlist of potentially appropriate studies for inclusion or exclusion. The full text of the article was obtained for further assessment to determine if the trial met the inclusion/exclusion criteria. A final consensus decision was made by discussion amongst all the review authors, if no consensus was met about the possible inclusion/exclusion of any individual study. We planned to submit the full article to the editorial board for arbitration, where there was still no consensus agreement regarding the inclusion/exclusion of a study, however, this was not required. Review authors were not be masked to the name(s) of the author(s), institution(s) or publication source at any level of the review. </p> <p>Further information about the method of randomisation or a complete description of the interventions from the trialists was sought when required. </p> </section> <section id="CD009974-sec-0045"> <h4 class="title">Data extraction and management</h4> <p>Four review authors (BA, FK, LLM, MD) independently extracted the data from each study that met the inclusion criteria, using a standardised data collection form. A final check was made by the fifth review author (DW). We contacted the primary authors of potentially eligible studies to provide data and clarification, where adequate data were not reported. All studies that met the inclusion criteria were summarised in the '<a href="./references#CD009974-sec-0092" title="">Characteristics of included studies</a>' table provided in the Review Manager (RevMan) 5 software developed by The Cochrane Collaboration (<a href="./references#CD009974-bbs2-0064" title="The Nordic Cochrane Centre,The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre,The Cochrane Collaboration, 2011. ">RevMan 2011</a>) and included details on design, participants, interventions and outcomes. </p> <p>The following information from individual studies was reported:</p> <p> <ul id="CD009974-list-0012"> <li> <p>publication details;</p> </li> <li> <p>study design, study setting, inclusion/exclusion criteria, method of allocation, risk of bias; </p> </li> <li> <p>patient population, for example, age, type of MS, disease duration, disability (according to Kurtzke's Expanded Disability Status Scale (EDSS) score; <a href="./references#CD009974-bbs2-0042" title="KurtzkeJF . Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology1983;33(11):1444‐52. ">Kurtzke 1983</a>)); </p> </li> <li> <p>details on spasticity (severity and affected side);</p> </li> <li> <p>details of intervention;</p> </li> <li> <p>outcome measures;</p> </li> <li> <p>withdrawals, length and method of follow‐up and number of participants followed up.</p> </li> </ul> </p> <p>Further details were requested from the main author of the manuscript or studies where detailed data were missing. </p> </section> <section id="CD009974-sec-0046"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Four review authors (BA, FK, LLM, MD) independently assessed the methodological quality of the included studies using the Cochrane 'Risk of bias' tool (<a href="./references#CD009974-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from: www.cochrane‐handbook.org. ">Higgins 2011</a>). We assessed the sequence generation, allocation concealment, blinding of participants, therapists and outcome assessors, incomplete outcome data and selective outcome reporting. A judgement of ‘yes’ indicated a low risk of bias, ‘no’ indicated a high risk of bias, and ‘unclear’ indicated either unclear or unknown risk of bias. See <a href="#CD009974-tbl-0001">Table 1</a>. </p> <div class="table" id="CD009974-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Levels of quality of individual studies</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Judgement of risk of bias</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk of bias in all domains low</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High methodological quality = ‘high‐quality study’</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear or high risk of bias for one or more domains</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low methodological quality = ‘low‐quality study’</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk of bias for most domains</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low methodological quality = ‘very low‐quality study’</p> </td> </tr> </tbody> </table> </div> <p>We considered studies to be of high methodological quality if the risk of bias for all domains was low. We termed these studies 'high‐quality studies'. We rated studies as low methodological quality where there was unclear or high risk of bias for one or more domains and termed these 'low‐quality studies' (see <a href="#CD009974-tbl-0002">Table 2</a>). Any disagreements or lack of consensus was resolved by a fifth review author (DW). </p> <div class="table" id="CD009974-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Levels of quality of a body of evidence in the GRADE approach  </span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Underlying methodology</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality rating</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised trials or double‐upgraded observational studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Downgraded randomised trials or upgraded observational studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Double‐downgraded randomised trials or observational studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Triple‐downgraded randomised trials or downgraded observational studies or case series/case reports </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD009974-sec-0047"> <h4 class="title">Measures of treatment effect</h4> <p>All data were entered and analysed in RevMan 5 (<a href="./references#CD009974-bbs2-0064" title="The Nordic Cochrane Centre,The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre,The Cochrane Collaboration, 2011. ">RevMan 2011</a>). A quantitative analysis was not possible due to clinical heterogeneity; the use of diverse methods, interventions and outcome measures; and insufficient data available. If studies had been available, we would have calculated risk ratios (RR) with 95% confidence intervals (CIs) for dichotomous data and differences in means or standardised differences in means (SMD) with 95% CIs for continuous data. We would also have calculated for each outcome of interest, summary estimates of treatment effect (with 95% CIs for each comparison). We qualitatively summarised the studies in the <a href="./references#CD009974-sec-0092" title="">Characteristics of included studies</a>, presented the results of individual studies in the <a href="#CD009974-tbl-0003">Table 3</a> and described the results in the <a href="#CD009974-sec-0072">Discussion</a> section below. </p> <div class="table" id="CD009974-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Summary of the findings</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Assessment points</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Summary of results</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Results – outcomes in favour of intervention group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Author’s conclusions</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009974-bbs2-0001" title="GiovannelliM , BorrielloG , CastriP , ProsperiniL , PozzilliC . Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clinical Rehabilitation2007;21(4):331‐7. ">Giovannelli 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline, and weeks 2, 4, and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD009974-list-0013"> <li> <p>Significant decrease in spasticity in treatment group compared to control group in MAS scores at weeks 2, 4, and 12, and in VAS rating scale at weeks 4 and 12 </p> </li> <li> <p>Control group MAS showed a transient decrease at week 2 and a slight increase at week 4 and week 12 </p> </li> </ul> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant decrease in MAS score in treatment group from baseline at (Mean (SD) change score): </p> <p> <ul id="CD009974-list-0014"> <li> <p>Week 2 : treatment group:‐0.91 (0.52) ; control group: ‐0.39 (0.50); P &lt; 0.01</p> </li> <li> <p>Week 4 : treatment group: ‐1.0 (0.69); control group ‐0.28 (0.46); P &lt; 0.01</p> </li> <li> <p>Week 12 : treatment group ‐0.95 (0.78); control group: ‐0.28 (0.46); P &lt; 0.01</p> </li> </ul> </p> <p>The mean (%) difference in MAS between baseline and the end of follow‐up was –0.95 (26.1) in the treatment group and –0.28 (7.7) in the control group (P &lt; 0.01). </p> <p> </p> <p>Significant improvement in spasticity in VAS rating scale (Mean (SD) change):</p> <p> <ul id="CD009974-list-0015"> <li> <p>Week 2 to week 4 : treatment group 1.77 (0.87) ; control group: 0 (1.08); P &lt; 0.01</p> </li> <li> <p>Week 4 to week 12: treatment group : 2.68 (1.08); control group: 1.06 (1.16); P &lt; 0.01 </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Addition of active physiotherapy after intramuscular botulin toxin increases reduction in spasticity even at 12 weeks. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009974-bbs2-0002" title="LappinMS , LawrieFW , RichardsTL , KramerED . Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double‐blind, placebo controlled trial. Alternative Therapies in Health and Medicine2003;9:38‐48. ">Lappin 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Before (baseline) and after 4 week treatment spell (week 4 and 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD009974-list-0016"> <li> <p>Significantly greater Improvement in fatigue and overall QOL in the active device compared with control group </p> </li> <li> <p>No significant differences in the treatment effects for bladder control (P = 0.26) (MSQLI) and disability composite (P = 0.77) (MSPS) </p> </li> <li> <p>Mixed result for spasticity: no significant difference in the treatment effects on daily diary ratings but MSQLI measure at the end of each sessions showed statistically significant differences (P = 0.04) </p> </li> <li> <p>The 3 scales (fatigue, pain and spasticity) used to create the QLI showed moderate inter‐correlations (r = 0.32 to 0.60), however, bladder control scale showed poor correlation with other MSQLI scales (r = 0.00 to 0.26) </p> </li> <li> <p>Adverse events: headaches, dizziness, numbness, fatigue, severe nausea</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean change scores between active vs. placebo groups::</p> <p> <ul id="CD009974-list-0017"> <li> <p>Bladder‐ 0.08 ; P = 0.26</p> </li> <li> <p>Spasms ‐ 0.13; P = 0.04</p> </li> <li> <p>Fatigue ‐0.14  ; P = 0.04</p> </li> <li> <p>3 item QOL ‐0.12; P = 0.03</p> </li> <li> <p>Disability level (8‐MSPS) – 0.12; P = 0.77</p> </li> </ul> </p> <p>No further data or analysis reported for spasms/spasticity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Although the clinical effects seen in the intervention group were small, exposure of people with MS to pulsing weak electromagnetic fields can alleviate some of their symptoms. </p> <p>More response on less severely disabled people.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009974-bbs2-0003" title="MillerL , MattisonP , PaulL , WoodL . The effects of Transcutaneous Electrical Nerve Stimulation (TENS) on spasticity in Multiple Sclerosis. Multiple Sclerosis2007;13:527‐33. ">Miller 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline and after (2 weeks) treatments; and follow‐up (8‐20 months) for the questionnaires for patient report for symptoms </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant differences in the Global Spasticity Score following either 60 minutes or 8 hours daily of TENS (P = 0.433 and 0.217 respectively) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD009974-list-0018"> <li> <p>8 hour TENS application time compared with the shorter 60 minute application time led to significant reduction in muscle spasm (P = 0.038) and pain (P = 0.008) </p> </li> <li> <p>At the end of the study (8‐20 months) patients reported reduction in symptoms: 87.5% for spasm, 73.3% for pain and 73.3% for stiffness </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TENS is not effective in reducing spasticity, but longer application time may be useful in treating pain and muscle spasm in people with MS. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009974-bbs2-0004" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , BoffaL , RimanoA , et al. Effects of Intermittent Theta Burst Stimulation on spasticity in patients with Multiple Sclerosis. European Journal of Neurology2010;17:295‐300. ">Mori 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline and after treatment (immediately after first sessions, 2 weeks) and follow‐up of each week up to 4 weeks post treatment) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Signiﬁcant reduction of H/M amplitude ratio and MAS  scores 1 week after the iTBS and persisting up to 2 weeks after  the  end  of  stimulation  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 weeks post iTBS treatment showed:</p> <p> <ul id="CD009974-list-0019"> <li> <p>Significant change in H/M amplitude ratio measured from the stimulated leg (P &lt; 0.01)</p> </li> <li> <p>Significant effect on MAS score measured from the stimulation target limb (P &lt; 0.001)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>iTBS is, a safe, non‐invasive, well‐tolerated and feasible protocol, and  a promising tool for the treatment of spasticity in MS. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009974-bbs2-0005" title="MoriF , LjokaC , MagniE , CodecaC , KusayanagiH , MonteleoneF , et al. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. Journal of Neurology2011;258(7):1281‐7. ">Mori 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline and after treatment (2 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD009974-list-0020"> <li> <p>Reduction in MAS, MSSS‐88, FSS scores, while in the Barthel index and MSQOL‐54, physical composite scores were increased, in iTBS and exercise group. </p> </li> <li> <p>·iTBS alone group showed a reduction of the MAS score.</p> </li> <li> <p>None of the measured scales showed significant changes in sham iTBS and exercise group</p> </li> </ul> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant improvement in the  iTBS and exercise group but not in the sham stimulation and exercise group in: </p> <p> <ul id="CD009974-list-0021"> <li> <p>MAS from the stimulated leg (2.1 ± 0.4 before treatment; 1.3 ± 0.4 after treatment; P &lt; 0.05) </p> </li> <li> <p>MSSS‐88 (74.3 ± 11.4 before treatment; 53.2 ± 10.9 after treatment; P &lt; 0.001)</p> </li> <li> <p>FSS (39.5 ± 4.2 before treatment; 31.6 ± 4.6 after treatment; P &lt; 0.05),</p> </li> <li> <p>Barthel index (92.5 ± 2.4 before treatment; 95.0 ± 1.85 after treatment; P &lt; 0.05)</p> </li> <li> <p>MSQOL‐54 physical health composite (59.7 ± 2.7 before treatment; 64.8 ± 2.7 after treatment; P &lt; 0.05) scores after treatment </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>iTBS associated with exercise therapy is a promising tool for motor rehabilitation of MS patients. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009974-bbs2-0006" title="NielsenJF , SinkjaerT , JakobsenJ . Treatment of spasticity with repetitive magnetic stimulation; a double‐blind placebo‐controlled study. Multiple Sclerosis1996;2(5):227‐32. ">Nielsen 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline  and after treatment (1 day, 8 days, and 16 days)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD009974-list-0022"> <li> <p>Significant improvement in clinical spasticity score (Ashworth Scale) in intervention group (rTMS) compared to control group </p> </li> <li> <p>Significant improvement in self‐score of ease of daily activities in both groups</p> </li> </ul> <ul id="CD009974-list-0023"> <li> <p>Significant improvement in stretch reflex thresh hold in both groups</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At day 1 post treatment:</p> <p> <ul id="CD009974-list-0024"> <li> <p>Ashworth Scale score for clinical spasticity improved significantly in treatment group compared to control group ( mean change ‐3.3 ± 4.7 AU vs. 0.7 ± 2.5 AU, P = 0.003) </p> </li> <li> <p>Self‐score of ease of daily day activities improved significantly in both groups (P &lt; 0.05 for both groups), but was no difference between the two groups. </p> </li> <li> <p>Threshold of the stretch reflex significantly increased in treatment group compared to control group (4.3±7.5 deg/s vs. ‐3.8 ± 9.7 deg/s, P = 0.001) </p> </li> </ul> </p> <p>At day 8 post treatment</p> <p> <ul id="CD009974-list-0025"> <li> <p>Threshold of the stretch reflex remain improved significantly in treatment group compared to control group (4.4 ± 7.5 deg/s vs. ‐1.8 ± 8.5 deg/s, P = 0.028) </p> </li> <li> <p>No statistically significant difference in clinical spasticity score or self‐score of ease of daily day activities between two groups </p> </li> </ul> </p> <p>At day 16 post treatment</p> <p> <ul id="CD009974-list-0026"> <li> <p>No statistically significant difference in any of the scores between two groups</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>rTMS has an short‐lasting antispastic effect in MS.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009974-bbs2-0007" title="RichardsTL , LappinMS , Acosta‐UrquidiJ , KraftGH , HeideAC , LawrieFW , et al. Double‐blind study of pulsing magnetic field effects on multiple sclerosis. Journal of Alternative &amp; Complementary Medicine1997;3(1):21‐9. ">Richards 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline  and after treatment (2 months)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD009974-list-0027"> <li> <p>No significant  change between  pre‐treatment  and  post‐treatment  in  the  EDSS  scale </p> </li> <li> <p>Significant  improvement in the performance  scale  (PS) combined  rating for bladder control, cognitive  function, fatigue  level,  mobility,  spasticity,  and vision  </p> </li> <li> <p>Significant  change  between  pre‐treatment  and  post‐treatment  in  alpha  EEG magnitude  during  the language  task </p> </li> <li> <p>Adverse events: headache, psychological problems, dizziness, increase spasm, skin irritation, nausea, exacerbation of MS </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant difference between pre‐treatment and post treatment within the treatment group in (mean (SD): </p> <p> <ul id="CD009974-list-0028"> <li> <p>Spasticity:  ‐0.80 (0.23); P &lt; 0.005</p> </li> <li> <p>Bladder control: ‐0.5 (0.23); P &lt; 0.05</p> </li> <li> <p>Cognition: ‐0.63 (0.37); P &lt; 0.05</p> </li> <li> <p>Fatigue: ‐0.87 (0.4); P &lt; 0.05</p> </li> <li> <p>Mobility: ‐0.4 (0.27); P &lt; 0.05</p> </li> <li> <p>Vision: ‐0.23 (0.21); P &lt; 0.05</p> </li> </ul> </p> <p>No adverse events: 6 in treatment group, 7 in control group.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Beneficial effect  of pulsing magnetic fields on MS patients treated  for a  period of 2 months, which is far too short to assess its effects  on the long‐term progression of MS. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009974-bbs2-0008" title="SchynsF , PaulL , FinlayK , FergusonC , NobleE . Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clinical Rehabilitation2009;23(9):771‐81. ">Schyns 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline  and after treatment (4 weeks) twice with 2 weeks cool‐off period (final at 12 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD009974-list-0029"> <li> <p>Exercise programme had positive effects on muscle force and well being</p> </li> <li> <p>Insufficient evidence that the addition of WBV provided any further benefit</p> </li> <li> <p>No change in MAS scores for either intervention,</p> </li> <li> <p>MSSS‐88 showed whole body vibration and exercises reduced muscle spasms in both groups (P = 0.02) </p> </li> <li> <p>10‐m walk and Timed Up and Go Test improved, but was not statistically significant</p> </li> <li> <p>No effects on sensation</p> </li> <li> <p>Adverse event: exacerbate a pre‐existing knee condition (N = 1)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD009974-list-0030"> <li> <p>Tone tended to increase more for exercise alone compared with whole body vibration and exercise </p> </li> <li> <p>MSSS‐88 pain: statistically significant difference between the results before and after whole body vibration in treatment group (P = 0.036) and no significant difference for control group </p> </li> <li> <p>MSSS‐88 spasm: greater reduction in score was achieved using whole body vibration and exercise compared to exercise alone (P = 0.02, 95% CI = 2.00, 14.50) </p> </li> <li> <p>No statistically significant changes for other MSSS‐88 components (ADL, social functioning, stiffness, gait, body movement and emotional health) </p> </li> <li> <p>10‐m walk time: both interventions increased the subjects’ walking speed , however the difference between performance with vibration and exercise, and exercise alone was not statistically significant (P = 0.561). A similar pattern was observed with the results of the Timed Up and Go Test (P = 0.720) </p> </li> <li> <p>MSIS‐29: overall well being improved in both groups, however, there was no statistically significant difference between groups </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise may be beneficial to those with MS, but there is limited evidence that the addition of WBV provides any additional improvements. </p> <p>Exercise performed three times a week for four weeks <br/> improved muscle force output, functional ability and general well‐being in people with MS and addition of whole body vibration to the exercise programme provided some added benefit to exercise alone in terms of reducing muscle spasm. </p> <p>In addition there was a trend towards a greater increase in muscle force generation with the addition of WBV. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009974-bbs2-0009" title="VelikonjaO , CuricK , OzuraA , JazbecSS . Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis. Clinical Neurology &amp; Neurosurgery2010;112(7):597‐601. ">Velkonja 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline  and after treatment (10 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD009974-list-0031"> <li> <p>No significant improvements in spasticity after both interventions (sports climbing (SC) or yoga) </p> </li> <li> <p>Significant reduction in fatigue in SC group, while yoga had no effect</p> </li> <li> <p>No differences in executive function</p> </li> <li> <p>No significant impact of SC and yoga on mood.</p> </li> <li> <p>Increase in selective attention performance in the yoga group (17% increase; baseline: 151.0 (94.5–175.5); after: 176.5 (116.5–191.3; P = 0.005). </p> </li> </ul> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD009974-list-0032"> <li> <p>SC group had 25% reduction (P = 0.046) in EDSSpyr; before  4.0 (3.0–4.0) after 3.0 (2.5–4.0) </p> </li> <li> <p>SC reduced fatigue for 32.5% (P = 0.015)</p> </li> <li> <p>Significant effect of SC on the level of fatigue (P = 0.015) as evaluated with the MFIS </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yoga and SC might improve some of the MS symptoms and should be considered in the future as possible complementary treatments. </p> <p> </p> <p>Unable to prove that SC and yoga have an effect on spasticity or mood in patients with MS. SC did not significantly affect performance on tests of selective attention and executive functions, while in the yoga group there was an improvement in selective attention performance and no effect on executive functions. There was a decrease in the level of everyday fatigue in patients with SC but not in the yoga group. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ADL = activities of daily living; BoNT = botulinum toxin type A; EDSS = Expanded Disability Status Scale; EDSSpyr = EDSS pyramidal functions score; FSS = Fatigue Severity Scale; HRQOL = health‐related quality of life; iTBS = Intermittent Theta Burst Stimulation; MAS = Modified Ashworth Scale; MFIS = Modified Fatigue Impact Scale; MS = Multiple Sclerosis; MSQLI = MS Quality of Life Inventory; MSIS‐29 = Multiple Sclerosis Impact Scale; MSSS‐88 = Multiple Sclerosis Spasticity Scale; MSPS = MS Performance Scale; QLI = quality of life index; QOL = quality of life; SC = Sports climbing; SD = standard deviation; TENS = Transcutaneous Electric Nerve Stimulation; rTMS = Repetitive Transcranial Magnetic Stimulation; VAS = Visual Analogue Scale; WBV = Whole Body Vibration </p> </div> </div> </section> <section id="CD009974-sec-0048"> <h4 class="title">Unit of analysis issues</h4> <p>The intended appropriate unit of analysis was type, intensity and setting of non pharmacological intervention, however, this was not possible. We analysed the methodological quality of RCTs using the GRADE system for existing evidence (<a href="./references#CD009974-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from: www.cochrane‐handbook.org. ">Higgins 2011</a>). The GRADE approach is applicable to all types of studies. The three levels of quality using the GRADE approach and the four levels of grading the body of evidence of included studies are shown in <a href="#CD009974-tbl-0001">Table 1</a> and <a href="#CD009974-tbl-0002">Table 2</a>. </p> </section> <section id="CD009974-sec-0049"> <h4 class="title">Dealing with missing data</h4> <p>We contacted the primary authors of potentially eligible studies to provide data and clarification, where required. We excluded studies with fatal flaws (for instance, withdrawals by more than 40% of the patients, nearly total non adherence to the protocol, or very poor or non adjusted comparability in the baseline criteria) (<a href="./references#CD009974-bbs2-0040" title="KhanF , Turner‐StokesL , NgL , KilpatrickT , AmatyaB . Multidisciplinary rehabilitation for adults with multiple sclerosis. Cochrane Database of Systematic Reviews2007, Issue 2. [DOI: 10.1002/14651858.CD006036] ">Khan 2007</a>; <a href="./references#CD009974-bbs2-0072" title="Turner‐StokesL , NairA , SedkiI , DislerPB , WadeDT . Multi‐disciplinary rehabilitation for acquired brain injury in adults of working age. Cochrane Database of Systematic Reviews2011, Issue 1. [DOI: 10.1002/14651858.CD004170.pub2] ">Turner‐Stokes 2011</a>; <a href="./references#CD009974-bbs2-0074" title="vanTulderMW , AssendelftWJ , KoesBW , BouterLM . Method guidelines for systematic reviews in the Cochrane Collaborations Back Review Group for Spinal Disorders. Spine1997;22:2323‐30. ">van Tulder 1997</a>; <a href="./references#CD009974-bbs2-0075" title="VanTulderMW , FurlanA , BombardierC , BouterL . Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group. Spine2003;28(12):1290‐9. ">Van Tulder 2003</a>). </p> </section> <section id="CD009974-sec-0050"> <h4 class="title">Assessment of heterogeneity</h4> <p>We followed statistical analysis as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009974-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from: www.cochrane‐handbook.org. ">Higgins 2011</a>).  As mentioned above, it was not possible to conduct a comprehensive quantitative analysis owing to the variability of interventions and methods used, and the type of available data reported in each study. </p> </section> <section id="CD009974-sec-0051"> <h4 class="title">Assessment of reporting biases</h4> <p>Publication bias was minimised by sourcing unpublished data where possible (<a href="./references#CD009974-bbs2-0031" title="EggerM , SmithGD . Bias in location and selection of studies. BMJ1998;316(7124):61‐6. ">Egger 1998</a>). We contacted the authors for the full data set or the reason for not publishing the data, where data were not reported or published in full. </p> </section> <section id="CD009974-sec-0052"> <h4 class="title">Data synthesis</h4> <p>For reasons mentioned above, data were not pooled for a quantitative analysis. If studies had been available, we would have attempted a quantitative analysis provided there was clinical homogeneity and the data in each study allowed for such an analysis. We would also have calculated a weighted treatment effect across trials using the Cochrane statistical package Review Manager 5 (RevMan 5) and expressed the results as risk ratios (RRs) with 95% CIs and risk differences (RDs) with 95% CIs for dichotomous outcomes and mean differences (MDs) and 95% CIs for continuous outcomes. We would have initially used a fixed‐effect model and approximate Chi<sup>2</sup> tests for heterogeneity to assess outcome data for compatibility with the assumption of a uniform risk ratio (P &gt; 0.10). In the presence of significant heterogeneity (P &lt; 0.10), random‐effects meta‐analysis would have been used instead. </p> <p>We have highlighted the strength of study findings, discussed gaps in current literature and identified future research directions in the <a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008505.pub2/full#CD008505-sec1-0005#CD008505-sec1-0005" target="_blank">Discussion</a> section. </p> </section> <section id="CD009974-sec-0053"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We were unable to perform subgroup analysis for the following subgroups owing to the lack of available data. </p> <p> <ol id="CD009974-list-0033"> <li> <p>Type of MS (relapsing remitting, progressive)</p> </li> <li> <p>EDSS (&lt; 6, &gt; 6)</p> </li> <li> <p>Duration of follow‐up of the participants (≤ three months; &gt; three months)</p> </li> <li> <p>Affected site, i.e. upper limb, lower limb or both</p> </li> <li> <p>Type of non pharmacological (uni‐disciplinary and/or multidisciplinary rehabilitation) intervention (i.e. inpatient, ambulatory care) </p> </li> </ol> </p> </section> <section id="CD009974-sec-0054"> <h4 class="title">Sensitivity analysis</h4> <p>We were not able to perform a sensitivity analyses. If studies had been available, and heterogeneity existed across trials, sensitivity analyses would have been conducted by omitting trials with a high risk of bias as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009974-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from: www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009974-sec-0055" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009974-sec-0055"></div> <section id="CD009974-sec-0056"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD009974-sec-0092" title="">Characteristics of included studies</a> and <a href="./references#CD009974-sec-0093" title="">Characteristics of excluded studies</a>. </p> <section id="CD009974-sec-0057"> <h4 class="title">Results of the search</h4> <p>Electronic and manual searches identified 384 references (MEDLINE = 243; EMBASE = 52; CENTRAL = 22; CINAHL = 18; PEDro = 0; LILACS = 3; CRD database = 11; Trial Registries via WHO Portal = 4; handsearch = 21; handsearching trial registries = 10) with our search criteria. Of these, 31 passed the first screening review and were selected for closer scrutiny. In total, full text of 17 articles were retrieved for further assessment to determine the inclusion. Two potentially relevant articles were also identified from bibliographies of papers identified. (see: <a href="#CD009974-fig-0001">Figure 1</a> for Study flow chart). </p> <div class="figure" id="CD009974-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD009974-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009974.pub2/media/CDSR/CD009974/image_n/nCD009974-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD009974-sec-0058"> <h4 class="title">Included studies</h4> <p>In total, nine RCTs (<a href="./references#CD009974-bbs2-0001" title="GiovannelliM , BorrielloG , CastriP , ProsperiniL , PozzilliC . Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clinical Rehabilitation2007;21(4):331‐7. ">Giovannelli 2007</a>; <a href="./references#CD009974-bbs2-0002" title="LappinMS , LawrieFW , RichardsTL , KramerED . Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double‐blind, placebo controlled trial. Alternative Therapies in Health and Medicine2003;9:38‐48. ">Lappin 2003</a>; <a href="./references#CD009974-bbs2-0003" title="MillerL , MattisonP , PaulL , WoodL . The effects of Transcutaneous Electrical Nerve Stimulation (TENS) on spasticity in Multiple Sclerosis. Multiple Sclerosis2007;13:527‐33. ">Miller 2007</a>; <a href="./references#CD009974-bbs2-0004" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , BoffaL , RimanoA , et al. Effects of Intermittent Theta Burst Stimulation on spasticity in patients with Multiple Sclerosis. European Journal of Neurology2010;17:295‐300. ">Mori 2010</a>; <a href="./references#CD009974-bbs2-0005" title="MoriF , LjokaC , MagniE , CodecaC , KusayanagiH , MonteleoneF , et al. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. Journal of Neurology2011;258(7):1281‐7. ">Mori 2011</a>; <a href="./references#CD009974-bbs2-0006" title="NielsenJF , SinkjaerT , JakobsenJ . Treatment of spasticity with repetitive magnetic stimulation; a double‐blind placebo‐controlled study. Multiple Sclerosis1996;2(5):227‐32. ">Nielsen 1996</a>; <a href="./references#CD009974-bbs2-0007" title="RichardsTL , LappinMS , Acosta‐UrquidiJ , KraftGH , HeideAC , LawrieFW , et al. Double‐blind study of pulsing magnetic field effects on multiple sclerosis. Journal of Alternative &amp; Complementary Medicine1997;3(1):21‐9. ">Richards 1997</a>; <a href="./references#CD009974-bbs2-0008" title="SchynsF , PaulL , FinlayK , FergusonC , NobleE . Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clinical Rehabilitation2009;23(9):771‐81. ">Schyns 2009</a>; <a href="./references#CD009974-bbs2-0009" title="VelikonjaO , CuricK , OzuraA , JazbecSS . Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis. Clinical Neurology &amp; Neurosurgery2010;112(7):597‐601. ">Velkonja 2010</a>) involving a total of 341 participants (301 included in analyses), fulfilled the inclusion criteria for this review (see <a href="./references#CD009974-sec-0092" title="">Characteristics of included studies</a> table). A majority of the included studies were conducted in Europe; three in Italy, <a href="./references#CD009974-bbs2-0001" title="GiovannelliM , BorrielloG , CastriP , ProsperiniL , PozzilliC . Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clinical Rehabilitation2007;21(4):331‐7. ">Giovannelli 2007</a>; <a href="./references#CD009974-bbs2-0004" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , BoffaL , RimanoA , et al. Effects of Intermittent Theta Burst Stimulation on spasticity in patients with Multiple Sclerosis. European Journal of Neurology2010;17:295‐300. ">Mori 2010</a>; <a href="./references#CD009974-bbs2-0005" title="MoriF , LjokaC , MagniE , CodecaC , KusayanagiH , MonteleoneF , et al. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. Journal of Neurology2011;258(7):1281‐7. ">Mori 2011</a>; two in United Kingdom, <a href="./references#CD009974-bbs2-0003" title="MillerL , MattisonP , PaulL , WoodL . The effects of Transcutaneous Electrical Nerve Stimulation (TENS) on spasticity in Multiple Sclerosis. Multiple Sclerosis2007;13:527‐33. ">Miller 2007</a>; <a href="./references#CD009974-bbs2-0008" title="SchynsF , PaulL , FinlayK , FergusonC , NobleE . Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clinical Rehabilitation2009;23(9):771‐81. ">Schyns 2009</a>; and one each in Slovenia, <a href="./references#CD009974-bbs2-0009" title="VelikonjaO , CuricK , OzuraA , JazbecSS . Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis. Clinical Neurology &amp; Neurosurgery2010;112(7):597‐601. ">Velkonja 2010</a>; and Denmark <a href="./references#CD009974-bbs2-0006" title="NielsenJF , SinkjaerT , JakobsenJ . Treatment of spasticity with repetitive magnetic stimulation; a double‐blind placebo‐controlled study. Multiple Sclerosis1996;2(5):227‐32. ">Nielsen 1996</a>, while two were conducted in United States (<a href="./references#CD009974-bbs2-0002" title="LappinMS , LawrieFW , RichardsTL , KramerED . Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double‐blind, placebo controlled trial. Alternative Therapies in Health and Medicine2003;9:38‐48. ">Lappin 2003</a>; <a href="./references#CD009974-bbs2-0007" title="RichardsTL , LappinMS , Acosta‐UrquidiJ , KraftGH , HeideAC , LawrieFW , et al. Double‐blind study of pulsing magnetic field effects on multiple sclerosis. Journal of Alternative &amp; Complementary Medicine1997;3(1):21‐9. ">Richards 1997</a>). The various non pharmacological interventions evaluated in the included studies consisted generally of physical activity programmes in isolation or concomitant with other interventions (pharmacological therapy or other non pharmacological intervention) and contemporary interventions. </p> <p> <ul id="CD009974-list-0034"> <li> <p>Four studies (<a href="./references#CD009974-bbs2-0001" title="GiovannelliM , BorrielloG , CastriP , ProsperiniL , PozzilliC . Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clinical Rehabilitation2007;21(4):331‐7. ">Giovannelli 2007</a>; <a href="./references#CD009974-bbs2-0005" title="MoriF , LjokaC , MagniE , CodecaC , KusayanagiH , MonteleoneF , et al. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. Journal of Neurology2011;258(7):1281‐7. ">Mori 2011</a>; <a href="./references#CD009974-bbs2-0008" title="SchynsF , PaulL , FinlayK , FergusonC , NobleE . Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clinical Rehabilitation2009;23(9):771‐81. ">Schyns 2009</a>; <a href="./references#CD009974-bbs2-0009" title="VelikonjaO , CuricK , OzuraA , JazbecSS . Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis. Clinical Neurology &amp; Neurosurgery2010;112(7):597‐601. ">Velkonja 2010</a>) evaluated various physical activity programmes. Of these, three studies compared these programmes in conjunction with other interventions: one study evaluated the effects of physiotherapy in combination with botulinum toxin type A (BoNT) injection (<a href="./references#CD009974-bbs2-0001" title="GiovannelliM , BorrielloG , CastriP , ProsperiniL , PozzilliC . Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clinical Rehabilitation2007;21(4):331‐7. ">Giovannelli 2007</a>), one explored the effects of an exercise programme in combination with Intermittent Theta Burst Stimulation (iTBS) (<a href="./references#CD009974-bbs2-0005" title="MoriF , LjokaC , MagniE , CodecaC , KusayanagiH , MonteleoneF , et al. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. Journal of Neurology2011;258(7):1281‐7. ">Mori 2011</a>), and another study evaluated the effects of whole body vibration (WBV) with or without an exercise programme (<a href="./references#CD009974-bbs2-0008" title="SchynsF , PaulL , FinlayK , FergusonC , NobleE . Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clinical Rehabilitation2009;23(9):771‐81. ">Schyns 2009</a>). One trial compared two contemporary physical activity programmes with each other: i.e. sports climbing with yoga (<a href="./references#CD009974-bbs2-0009" title="VelikonjaO , CuricK , OzuraA , JazbecSS . Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis. Clinical Neurology &amp; Neurosurgery2010;112(7):597‐601. ">Velkonja 2010</a>). </p> </li> <li> <p>Three studies evaluated the effectiveness of repetitive magnetic stimulation: two iTBS (<a href="./references#CD009974-bbs2-0004" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , BoffaL , RimanoA , et al. Effects of Intermittent Theta Burst Stimulation on spasticity in patients with Multiple Sclerosis. European Journal of Neurology2010;17:295‐300. ">Mori 2010</a>; <a href="./references#CD009974-bbs2-0005" title="MoriF , LjokaC , MagniE , CodecaC , KusayanagiH , MonteleoneF , et al. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. Journal of Neurology2011;258(7):1281‐7. ">Mori 2011</a>) and one Repetitive Transcranial Magnetic Stimulation (rTMS) (<a href="./references#CD009974-bbs2-0006" title="NielsenJF , SinkjaerT , JakobsenJ . Treatment of spasticity with repetitive magnetic stimulation; a double‐blind placebo‐controlled study. Multiple Sclerosis1996;2(5):227‐32. ">Nielsen 1996</a>). </p> </li> <li> <p>Two studies investigated the effectiveness of electromagnetic therapy: one Pulsed Electromagnetic Therapy (<a href="./references#CD009974-bbs2-0002" title="LappinMS , LawrieFW , RichardsTL , KramerED . Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double‐blind, placebo controlled trial. Alternative Therapies in Health and Medicine2003;9:38‐48. ">Lappin 2003</a>); and one magnetic pulsing device (Enermed) (<a href="./references#CD009974-bbs2-0007" title="RichardsTL , LappinMS , Acosta‐UrquidiJ , KraftGH , HeideAC , LawrieFW , et al. Double‐blind study of pulsing magnetic field effects on multiple sclerosis. Journal of Alternative &amp; Complementary Medicine1997;3(1):21‐9. ">Richards 1997</a>). </p> </li> <li> <p>One study each evaluated the impact of Transcutaneous Electric Nerve Stimulation (TENS) (<a href="./references#CD009974-bbs2-0003" title="MillerL , MattisonP , PaulL , WoodL . The effects of Transcutaneous Electrical Nerve Stimulation (TENS) on spasticity in Multiple Sclerosis. Multiple Sclerosis2007;13:527‐33. ">Miller 2007</a>) and WBV (<a href="./references#CD009974-bbs2-0008" title="SchynsF , PaulL , FinlayK , FergusonC , NobleE . Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clinical Rehabilitation2009;23(9):771‐81. ">Schyns 2009</a>). </p> </li> </ul> </p> <p>The review authors are unaware of any on‐going RCTs in this area.</p> <p>The study inclusion criteria varied between trials. All trials included participants with definite MS, however, only five trials specified the commonly used clinical criteria: three trials used the clinical criteria of Poser (<a href="./references#CD009974-bbs2-0002" title="LappinMS , LawrieFW , RichardsTL , KramerED . Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double‐blind, placebo controlled trial. Alternative Therapies in Health and Medicine2003;9:38‐48. ">Lappin 2003</a>; <a href="./references#CD009974-bbs2-0006" title="NielsenJF , SinkjaerT , JakobsenJ . Treatment of spasticity with repetitive magnetic stimulation; a double‐blind placebo‐controlled study. Multiple Sclerosis1996;2(5):227‐32. ">Nielsen 1996</a>; <a href="./references#CD009974-bbs2-0007" title="RichardsTL , LappinMS , Acosta‐UrquidiJ , KraftGH , HeideAC , LawrieFW , et al. Double‐blind study of pulsing magnetic field effects on multiple sclerosis. Journal of Alternative &amp; Complementary Medicine1997;3(1):21‐9. ">Richards 1997</a>), two the McDonald (<a href="./references#CD009974-bbs2-0004" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , BoffaL , RimanoA , et al. Effects of Intermittent Theta Burst Stimulation on spasticity in patients with Multiple Sclerosis. European Journal of Neurology2010;17:295‐300. ">Mori 2010</a>; <a href="./references#CD009974-bbs2-0005" title="MoriF , LjokaC , MagniE , CodecaC , KusayanagiH , MonteleoneF , et al. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. Journal of Neurology2011;258(7):1281‐7. ">Mori 2011</a>), and was unspecified in remaining four trials (<a href="./references#CD009974-bbs2-0001" title="GiovannelliM , BorrielloG , CastriP , ProsperiniL , PozzilliC . Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clinical Rehabilitation2007;21(4):331‐7. ">Giovannelli 2007</a>; <a href="./references#CD009974-bbs2-0003" title="MillerL , MattisonP , PaulL , WoodL . The effects of Transcutaneous Electrical Nerve Stimulation (TENS) on spasticity in Multiple Sclerosis. Multiple Sclerosis2007;13:527‐33. ">Miller 2007</a>; <a href="./references#CD009974-bbs2-0008" title="SchynsF , PaulL , FinlayK , FergusonC , NobleE . Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clinical Rehabilitation2009;23(9):771‐81. ">Schyns 2009</a>; <a href="./references#CD009974-bbs2-0009" title="VelikonjaO , CuricK , OzuraA , JazbecSS . Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis. Clinical Neurology &amp; Neurosurgery2010;112(7):597‐601. ">Velkonja 2010</a>). Most studies included all types of MS, while two studies included only participants with relapsing‐remitting MS (<a href="./references#CD009974-bbs2-0004" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , BoffaL , RimanoA , et al. Effects of Intermittent Theta Burst Stimulation on spasticity in patients with Multiple Sclerosis. European Journal of Neurology2010;17:295‐300. ">Mori 2010</a>; <a href="./references#CD009974-bbs2-0005" title="MoriF , LjokaC , MagniE , CodecaC , KusayanagiH , MonteleoneF , et al. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. Journal of Neurology2011;258(7):1281‐7. ">Mori 2011</a>) and one (<a href="./references#CD009974-bbs2-0001" title="GiovannelliM , BorrielloG , CastriP , ProsperiniL , PozzilliC . Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clinical Rehabilitation2007;21(4):331‐7. ">Giovannelli 2007</a>) only participants with secondary progressive MS. </p> <p>All studies required some form of disability/impairment scale score as an entry criteria between specified values. These included: Ashworth Scale score, MAS (<a href="./references#CD009974-bbs2-0001" title="GiovannelliM , BorrielloG , CastriP , ProsperiniL , PozzilliC . Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clinical Rehabilitation2007;21(4):331‐7. ">Giovannelli 2007</a>; <a href="./references#CD009974-bbs2-0003" title="MillerL , MattisonP , PaulL , WoodL . The effects of Transcutaneous Electrical Nerve Stimulation (TENS) on spasticity in Multiple Sclerosis. Multiple Sclerosis2007;13:527‐33. ">Miller 2007</a>; <a href="./references#CD009974-bbs2-0006" title="NielsenJF , SinkjaerT , JakobsenJ . Treatment of spasticity with repetitive magnetic stimulation; a double‐blind placebo‐controlled study. Multiple Sclerosis1996;2(5):227‐32. ">Nielsen 1996</a>), EDSS scores (<a href="./references#CD009974-bbs2-0004" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , BoffaL , RimanoA , et al. Effects of Intermittent Theta Burst Stimulation on spasticity in patients with Multiple Sclerosis. European Journal of Neurology2010;17:295‐300. ">Mori 2010</a>; <a href="./references#CD009974-bbs2-0005" title="MoriF , LjokaC , MagniE , CodecaC , KusayanagiH , MonteleoneF , et al. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. Journal of Neurology2011;258(7):1281‐7. ">Mori 2011</a>; <a href="./references#CD009974-bbs2-0009" title="VelikonjaO , CuricK , OzuraA , JazbecSS . Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis. Clinical Neurology &amp; Neurosurgery2010;112(7):597‐601. ">Velkonja 2010</a>), Hauser Ambulation Index (<a href="./references#CD009974-bbs2-0008" title="SchynsF , PaulL , FinlayK , FergusonC , NobleE . Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clinical Rehabilitation2009;23(9):771‐81. ">Schyns 2009</a>) and MS Symptom Rating Form (<a href="./references#CD009974-bbs2-0002" title="LappinMS , LawrieFW , RichardsTL , KramerED . Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double‐blind, placebo controlled trial. Alternative Therapies in Health and Medicine2003;9:38‐48. ">Lappin 2003</a>). </p> <p>The recruitment time period was not reported in any of the studies. The follow‐up periods varied between trials with most being immediately after treatment or up to two months. Only one trial reported long‐term follow‐up of up to eight to 20 months, but this was restricted only for evaluation of patient‐reported symptoms using subjective questionnaires (<a href="./references#CD009974-bbs2-0003" title="MillerL , MattisonP , PaulL , WoodL . The effects of Transcutaneous Electrical Nerve Stimulation (TENS) on spasticity in Multiple Sclerosis. Multiple Sclerosis2007;13:527‐33. ">Miller 2007</a>). For details of assessment time points for each trial refer to summary of findings in <a href="#CD009974-tbl-0003">Table 3</a>. </p> <p>All included studies reported at least one spasticity‐related outcome: group mean differences in EDSS, MAS pre‐treatment to post‐treatment, subjective ratings of improvement in individual symptoms. See <a href="./references#CD009974-sec-0092" title="">Characteristics of included studies</a> for details of clinical outcomes evaluated in each trial. Adverse events were reported only in three studies (<a href="./references#CD009974-bbs2-0002" title="LappinMS , LawrieFW , RichardsTL , KramerED . Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double‐blind, placebo controlled trial. Alternative Therapies in Health and Medicine2003;9:38‐48. ">Lappin 2003</a>; <a href="./references#CD009974-bbs2-0007" title="RichardsTL , LappinMS , Acosta‐UrquidiJ , KraftGH , HeideAC , LawrieFW , et al. Double‐blind study of pulsing magnetic field effects on multiple sclerosis. Journal of Alternative &amp; Complementary Medicine1997;3(1):21‐9. ">Richards 1997</a>; <a href="./references#CD009974-bbs2-0008" title="SchynsF , PaulL , FinlayK , FergusonC , NobleE . Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clinical Rehabilitation2009;23(9):771‐81. ">Schyns 2009</a>). </p> </section> <section id="CD009974-sec-0059"> <h4 class="title">Excluded studies</h4> <p>Ten studies were excluded after appraisals of the full report. See <a href="./references#CD009974-sec-0093" title="">Characteristics of excluded studies</a> table. The primary reasons for exclusion were: three were comparative, but not RCTs (<a href="./references#CD009974-bbs2-0012" title="ChiaraT , CarlosJJr , MartinD , MillerR , NadeauS . Cold effect on oxygen uptake, perceived exertion, and spasticity in patients with Multiple Sclerosis. Archives of Physical Medicine &amp; Rehabilitation1998;79:523‐8. ">Chiara 1998</a>; <a href="./references#CD009974-bbs2-0018" title="SosnoffJ , MotlRW , SnookEM , WynnD . Effect of a 4‐week period of unloaded leg cycling exercise on spasticity in multiple sclerosis. Neurorehabilitation2009;24:327‐31. ">Sosnoff 2009</a>; <a href="./references#CD009974-bbs2-0019" title="SzecsiJ , SchlickC , SchillerM , PollmannW , KoenigN , StraubeA . Functional electrical stimulation‐assisted cycling of patients with Multiple Sclerosis: biomechanical and functional outcome ‐ a pilot study. Journal of Rehabilitation Medicine2009;41:674‐80. ">Szecsi 2009</a>); four studies did not use spasticity as a specific outcome measure (<a href="./references#CD009974-bbs2-0011" title="Castro‐SanchezAM , Mataran‐PenarrochaGA , Lara‐PalomoI , Saavedra‐HernandezM , Arroyo‐MoralesM , Moreno‐LorenzoC . Hydrotherapy for the treatment of pain in people with Multiple Sclerosis: a randomized controlled trial.. Evidence‐Based Complementary and Alternatative Medicine2012;[Epub ahead of print]:DOI: 10.1155/2012/473963. ">Castro‐Sanchez 2012</a>; <a href="./references#CD009974-bbs2-0013" title="FarinelliM , BarattoL , BettiE , MorassoP Capra R , SpadaG . Acupuncture improves postural control in patients with lower limbs spasticity: a randomized controlled trial. Giornale Italiano di Riflessoterapia ed Agopuntura1999;11:71‐4. ">Farenelli 1999</a>; <a href="./references#CD009974-bbs2-0014" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15:1329‐38. ">Huges 2009</a>; <a href="./references#CD009974-bbs2-0016" title="LivesleyE . Effects of electrical neuromuscular stimulation on functional performance in patients with Multiple Sclerosis. Physiotherapy1992;78:914‐7. ">Livesley 1992</a>); and three were only abstracts of RCTs presented in various conferences (<a href="./references#CD009974-bbs2-0010" title="BernhardtL , MarziniakM . Specific resistance training for patients with multiple sclerosis. Multiple Sclerosis2011;17:S465. ">Bernhardt 2011</a>; <a href="./references#CD009974-bbs2-0015" title="LeocaniL , NuaraA , FormentiA , RossiP , ZangenA , ComolaM , et al. Deep rTMS with H‐Coil associated with rehabilitation enhances improvement of walking abilities in patients with progressive multiple sclerosis: randomized, controlled, double blind study. Neurology2012;259(Suppl 1):S1–S236. ">Leocani 2012</a>; <a href="./references#CD009974-bbs2-0017" title="ShaygannejadV , AshtariF , HaghighiS , VaeziA . The effect of Transcutaneous Electrical Nerve Stimulations on spasticity in Multiple Sclerosis patients in comparison with baclofen: a randomised single‐blinded clinical trial. Multiple Sclerosis2011;17:S246. ">Shaygannejad 2011</a>). To date, none of these abstracts have been published as full accounts and despite multiple attempts to contact the authors, detailed data were not obtained. </p> </section> </section> <section id="CD009974-sec-0060"> <h3 class="title">Risk of bias in included studies</h3> <p>See: 'Risk of bias’ tables in the <a href="./references#CD009974-sec-0092" title="">Characteristics of included studies</a> and <a href="#CD009974-fig-0002">Figure 2</a> and <a href="#CD009974-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD009974-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009974-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009974.pub2/media/CDSR/CD009974/image_n/nCD009974-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD009974-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009974-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009974.pub2/media/CDSR/CD009974/image_n/nCD009974-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p>Review authors’ judgements about each methodological quality item presented as percentages across all included studies are presented in <a href="#CD009974-fig-0003">Figure 3</a>.  Where studies failed to report sufficient methodological detail to assess potential risk of bias, we graded them as 'unclear' risk (<a href="#CD009974-fig-0002">Figure 2</a>). </p> <p>The methodological quality of the nine included trials was 'low'. All trials had substantial flaws in their methodological design with a high risk of bias related to their randomisation procedure; blinding of patients, therapists and outcome assessors; and outcome analysis. </p> <section id="CD009974-sec-0061"> <h4 class="title">Allocation</h4> <p>Concealment of allocation prior to entry to the study was described only in two studies (<a href="./references#CD009974-bbs2-0002" title="LappinMS , LawrieFW , RichardsTL , KramerED . Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double‐blind, placebo controlled trial. Alternative Therapies in Health and Medicine2003;9:38‐48. ">Lappin 2003</a>; <a href="./references#CD009974-bbs2-0007" title="RichardsTL , LappinMS , Acosta‐UrquidiJ , KraftGH , HeideAC , LawrieFW , et al. Double‐blind study of pulsing magnetic field effects on multiple sclerosis. Journal of Alternative &amp; Complementary Medicine1997;3(1):21‐9. ">Richards 1997</a>). Although all included studies stated the procedure to be randomised, methods of randomisation were reported in three studies only (<a href="./references#CD009974-bbs2-0001" title="GiovannelliM , BorrielloG , CastriP , ProsperiniL , PozzilliC . Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clinical Rehabilitation2007;21(4):331‐7. ">Giovannelli 2007</a>; <a href="./references#CD009974-bbs2-0002" title="LappinMS , LawrieFW , RichardsTL , KramerED . Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double‐blind, placebo controlled trial. Alternative Therapies in Health and Medicine2003;9:38‐48. ">Lappin 2003</a>; <a href="./references#CD009974-bbs2-0008" title="SchynsF , PaulL , FinlayK , FergusonC , NobleE . Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clinical Rehabilitation2009;23(9):771‐81. ">Schyns 2009</a>). </p> </section> <section id="CD009974-sec-0062"> <h4 class="title">Blinding</h4> <p>Blinding of study participants and treating personnel were adequately described only in three studies (<a href="./references#CD009974-bbs2-0002" title="LappinMS , LawrieFW , RichardsTL , KramerED . Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double‐blind, placebo controlled trial. Alternative Therapies in Health and Medicine2003;9:38‐48. ">Lappin 2003</a>; <a href="./references#CD009974-bbs2-0006" title="NielsenJF , SinkjaerT , JakobsenJ . Treatment of spasticity with repetitive magnetic stimulation; a double‐blind placebo‐controlled study. Multiple Sclerosis1996;2(5):227‐32. ">Nielsen 1996</a>; <a href="./references#CD009974-bbs2-0007" title="RichardsTL , LappinMS , Acosta‐UrquidiJ , KraftGH , HeideAC , LawrieFW , et al. Double‐blind study of pulsing magnetic field effects on multiple sclerosis. Journal of Alternative &amp; Complementary Medicine1997;3(1):21‐9. ">Richards 1997</a>), was not carried out in four studies (<a href="./references#CD009974-bbs2-0001" title="GiovannelliM , BorrielloG , CastriP , ProsperiniL , PozzilliC . Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clinical Rehabilitation2007;21(4):331‐7. ">Giovannelli 2007</a>; <a href="./references#CD009974-bbs2-0003" title="MillerL , MattisonP , PaulL , WoodL . The effects of Transcutaneous Electrical Nerve Stimulation (TENS) on spasticity in Multiple Sclerosis. Multiple Sclerosis2007;13:527‐33. ">Miller 2007</a>; <a href="./references#CD009974-bbs2-0008" title="SchynsF , PaulL , FinlayK , FergusonC , NobleE . Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clinical Rehabilitation2009;23(9):771‐81. ">Schyns 2009</a>; <a href="./references#CD009974-bbs2-0009" title="VelikonjaO , CuricK , OzuraA , JazbecSS . Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis. Clinical Neurology &amp; Neurosurgery2010;112(7):597‐601. ">Velkonja 2010</a>) and unclear in one study (<a href="./references#CD009974-bbs2-0004" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , BoffaL , RimanoA , et al. Effects of Intermittent Theta Burst Stimulation on spasticity in patients with Multiple Sclerosis. European Journal of Neurology2010;17:295‐300. ">Mori 2010</a>). One study (<a href="./references#CD009974-bbs2-0005" title="MoriF , LjokaC , MagniE , CodecaC , KusayanagiH , MonteleoneF , et al. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. Journal of Neurology2011;258(7):1281‐7. ">Mori 2011</a>) partially blinded the participants (only two of the three groups in which participants were allocated were blinded). None of the studies attempted to test the success of patient blinding by questionnaire. Blinding of participants and treating personnel can be challenging in rehabilitation, but blinding outcome assessors is possible. Only five studies took measures to blind outcome assessors (<a href="./references#CD009974-bbs2-0001" title="GiovannelliM , BorrielloG , CastriP , ProsperiniL , PozzilliC . Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clinical Rehabilitation2007;21(4):331‐7. ">Giovannelli 2007</a>; <a href="./references#CD009974-bbs2-0002" title="LappinMS , LawrieFW , RichardsTL , KramerED . Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double‐blind, placebo controlled trial. Alternative Therapies in Health and Medicine2003;9:38‐48. ">Lappin 2003</a>; <a href="./references#CD009974-bbs2-0004" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , BoffaL , RimanoA , et al. Effects of Intermittent Theta Burst Stimulation on spasticity in patients with Multiple Sclerosis. European Journal of Neurology2010;17:295‐300. ">Mori 2010</a>; <a href="./references#CD009974-bbs2-0007" title="RichardsTL , LappinMS , Acosta‐UrquidiJ , KraftGH , HeideAC , LawrieFW , et al. Double‐blind study of pulsing magnetic field effects on multiple sclerosis. Journal of Alternative &amp; Complementary Medicine1997;3(1):21‐9. ">Richards 1997</a>; <a href="./references#CD009974-bbs2-0008" title="SchynsF , PaulL , FinlayK , FergusonC , NobleE . Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clinical Rehabilitation2009;23(9):771‐81. ">Schyns 2009</a>). </p> </section> <section id="CD009974-sec-0063"> <h4 class="title">Incomplete outcome data</h4> <p>Eight of the nine included studies provided a description of participant withdrawals and losses to follow‐up. No participants withdrew or were lost to follow‐up in two studies (<a href="./references#CD009974-bbs2-0004" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , BoffaL , RimanoA , et al. Effects of Intermittent Theta Burst Stimulation on spasticity in patients with Multiple Sclerosis. European Journal of Neurology2010;17:295‐300. ">Mori 2010</a>; <a href="./references#CD009974-bbs2-0005" title="MoriF , LjokaC , MagniE , CodecaC , KusayanagiH , MonteleoneF , et al. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. Journal of Neurology2011;258(7):1281‐7. ">Mori 2011</a>), while one study (<a href="./references#CD009974-bbs2-0009" title="VelikonjaO , CuricK , OzuraA , JazbecSS . Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis. Clinical Neurology &amp; Neurosurgery2010;112(7):597‐601. ">Velkonja 2010</a>) did not report any information in this regard. Intention‐to‐treat analysis was not performed in any of the trials. In those studies with losses to follow‐up or withdrawals, participants who withdrew or did not continue the study were excluded from the analysis, and no information was available for these participants. </p> </section> <section id="CD009974-sec-0064"> <h4 class="title">Selective reporting</h4> <p>All included studies reported pre‐specified (primary and secondary) outcomes.</p> </section> <section id="CD009974-sec-0065"> <h4 class="title">Other potential sources of bias</h4> <p>Eight studies had small sample sizes (&lt; 40 participants). Only Lappin et al (<a href="./references#CD009974-bbs2-0002" title="LappinMS , LawrieFW , RichardsTL , KramerED . Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double‐blind, placebo controlled trial. Alternative Therapies in Health and Medicine2003;9:38‐48. ">Lappin 2003</a>) had adequate sample size (N = 117). A majority of the studies had short‐term follow‐ups and follow‐ups were restricted to immediate post‐treatment assessments. Two studies had differences in baseline characteristics amongst the two groups (<a href="./references#CD009974-bbs2-0003" title="MillerL , MattisonP , PaulL , WoodL . The effects of Transcutaneous Electrical Nerve Stimulation (TENS) on spasticity in Multiple Sclerosis. Multiple Sclerosis2007;13:527‐33. ">Miller 2007</a>; <a href="./references#CD009974-bbs2-0006" title="NielsenJF , SinkjaerT , JakobsenJ . Treatment of spasticity with repetitive magnetic stimulation; a double‐blind placebo‐controlled study. Multiple Sclerosis1996;2(5):227‐32. ">Nielsen 1996</a>). </p> </section> </section> <section id="CD009974-sec-0066"> <h3 class="title" id="CD009974-sec-0066">Effects of interventions</h3> <p>As mentioned earlier, a meta‐analysis was not performed due to heterogeneity of included studies. The included studies used a range of non pharmacological approaches to treat spasticity in people with MS, as well as various measures assessing other MS‐related symptoms. Outcome measures which were not directly related to treating spasticity e.g. cognition, bladder function, fatigue were excluded. A summary of the findings of the included trials is presented below. See <a href="#CD009974-tbl-0003">Table 3</a> for summary of results and conclusions reported by the authors of the individual studies. </p> <section id="CD009974-sec-0067"> <h4 class="title">Physical activity programme</h4> <p>Four studies (<a href="./references#CD009974-bbs2-0001" title="GiovannelliM , BorrielloG , CastriP , ProsperiniL , PozzilliC . Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clinical Rehabilitation2007;21(4):331‐7. ">Giovannelli 2007</a>; <a href="./references#CD009974-bbs2-0005" title="MoriF , LjokaC , MagniE , CodecaC , KusayanagiH , MonteleoneF , et al. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. Journal of Neurology2011;258(7):1281‐7. ">Mori 2011</a>; <a href="./references#CD009974-bbs2-0008" title="SchynsF , PaulL , FinlayK , FergusonC , NobleE . Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clinical Rehabilitation2009;23(9):771‐81. ">Schyns 2009</a>; <a href="./references#CD009974-bbs2-0009" title="VelikonjaO , CuricK , OzuraA , JazbecSS . Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis. Clinical Neurology &amp; Neurosurgery2010;112(7):597‐601. ">Velkonja 2010</a>) evaluated the impact of different types of physical activity programmes (including structured physiotherapy, exercise programme and sports climbing). Three studies evaluated these programmes in conjunction with other interventions: BoNT (<a href="./references#CD009974-bbs2-0001" title="GiovannelliM , BorrielloG , CastriP , ProsperiniL , PozzilliC . Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clinical Rehabilitation2007;21(4):331‐7. ">Giovannelli 2007</a>), iTBS (<a href="./references#CD009974-bbs2-0005" title="MoriF , LjokaC , MagniE , CodecaC , KusayanagiH , MonteleoneF , et al. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. Journal of Neurology2011;258(7):1281‐7. ">Mori 2011</a>) and vibration therapy (<a href="./references#CD009974-bbs2-0008" title="SchynsF , PaulL , FinlayK , FergusonC , NobleE . Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clinical Rehabilitation2009;23(9):771‐81. ">Schyns 2009</a>). </p> <p>One study (<a href="./references#CD009974-bbs2-0001" title="GiovannelliM , BorrielloG , CastriP , ProsperiniL , PozzilliC . Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clinical Rehabilitation2007;21(4):331‐7. ">Giovannelli 2007</a>) investigated whether additional physiotherapy increases BoNT effects in reducing spasticity in people with MS. This trial included 38 people with secondary progressive MS affected by focal spasticity. The intervention group received BoNT and additional daily physiotherapy for 15 days, encompassing passive or active exercise and stretching regimens. The control group received only BoNT. The treatment group compared with the control group, showed a significant decrease in spasticity, measured by MAS score: at week two (2.73 versus 3.22), week four (2.64 versus 3.33) and week 12 (2.68 versus 3.33), (P &lt; 0.01 for all time points). There was also a significant difference in MAS score between baseline and end of 12 weeks follow‐up in favour of the treatment group (mean difference (MD) (%) –0.95 (26.1) versus –0.28 (7.7), P &lt; 0.01). The combined treatment was also more effective in reducing spasticity symptoms as measured by visual analogue scale at week four (6.95 versus 5.50, P &lt; 0.01). </p> <p>One double‐blind, sham‐controlled trial (<a href="./references#CD009974-bbs2-0005" title="MoriF , LjokaC , MagniE , CodecaC , KusayanagiH , MonteleoneF , et al. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. Journal of Neurology2011;258(7):1281‐7. ">Mori 2011</a>) investigated whether the combination of iTBS and a programme of exercise therapy improves motor disability in people with MS. Thirty participants were randomised into three different groups: iTBS plus exercise therapy, sham stimulation plus exercise therapy, and iTBS alone. The outcomes assessed before and after two weeks of treatment include: spasticity or tone using MAS and 88 items Multiple Sclerosis Spasticity Score questionnaire (MSSS‐88), fatigue using Fatigue Severity Scale (FSS), ADL using Barthel index (BI) and health‐related quality of life (HRQOL) using 54 items Multiple Sclerosis Quality of life inventory (MSQOL‐54). There was a significant improvement in MAS scores in the stimulated leg (2.1 ± 0.4 before treatment; 1.3 ± 0.4 after treatment; P &lt; 0.05), MSSS‐88 (74.3 ± 11.4 before treatment; 53.2 ± 10.9 after treatment; P &lt; 0.001), FSS (39.5 ± 4.2 before treatment; 31.6 ± 4.6 after treatment; P &lt; 0.05), BI (92.5 ± 2.4 before treatment; 95.0 ± 1.85 after treatment; P &lt; 0.05), and MSQOL‐54 physical health composite (59.7 ± 2.7 before treatment; 64.8 ± 2.7 after treatment; P &lt; 0.05) scores after treatment in the iTBS plus exercise therapy group but not in the sham stimulation plus exercise therapy group. There was also a significant reduction of the MAS score in the iTBS group (3.3 ± 0.8 before treatment; 1.6 ± 0.8 after treatment; P &lt; 0.05), while other measures of MS‐related disability were not affected by this treatment. </p> <p>Velkonja et al (<a href="./references#CD009974-bbs2-0009" title="VelikonjaO , CuricK , OzuraA , JazbecSS . Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis. Clinical Neurology &amp; Neurosurgery2010;112(7):597‐601. ">Velkonja 2010</a>) investigated the effects of two different contemporary aerobic physical activities: sports climbing and yoga (both compromising a series of stretching techniques, implementation of which demands body control and planning of complex movements) on spasticity, cognitive impairment, mood change and fatigue in people with MS. This trial included 20 participants with relapsing remitting or progressive MS randomly allocated to both groups for a 10‐week intervention period. There were no significant improvements in spasticity after both interventions (measured using MAS). In the sports climbing group there was a significant reduction in EDSS pyramidal functions score (25% reduction post‐treatment, P = 0.046), while in the yoga group there was a significant increase in selective attention performance (17% improvement post‐treatment, P = 0.005). There was also a significant reduction in fatigue in the sports climbing group (32.5%, P = 0.015), while yoga had no effect. </p> <p>One trial (<a href="./references#CD009974-bbs2-0008" title="SchynsF , PaulL , FinlayK , FergusonC , NobleE . Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clinical Rehabilitation2009;23(9):771‐81. ">Schyns 2009</a>), which investigated the effects of the combination of vibration therapy with or without exercise programme, is summarised below under the 'Vibration therapy' subheading. </p> </section> <section id="CD009974-sec-0068"> <h4 class="title">Repetitive magnetic stimulation</h4> <p>Three studies investigated the effects of repetitive magnetic stimulation on spasticity in people with MS: two iTBS (<a href="./references#CD009974-bbs2-0004" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , BoffaL , RimanoA , et al. Effects of Intermittent Theta Burst Stimulation on spasticity in patients with Multiple Sclerosis. European Journal of Neurology2010;17:295‐300. ">Mori 2010</a>; <a href="./references#CD009974-bbs2-0005" title="MoriF , LjokaC , MagniE , CodecaC , KusayanagiH , MonteleoneF , et al. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. Journal of Neurology2011;258(7):1281‐7. ">Mori 2011</a>) and one rTMS (<a href="./references#CD009974-bbs2-0006" title="NielsenJF , SinkjaerT , JakobsenJ . Treatment of spasticity with repetitive magnetic stimulation; a double‐blind placebo‐controlled study. Multiple Sclerosis1996;2(5):227‐32. ">Nielsen 1996</a>). </p> <p>One trial (<a href="./references#CD009974-bbs2-0005" title="MoriF , LjokaC , MagniE , CodecaC , KusayanagiH , MonteleoneF , et al. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. Journal of Neurology2011;258(7):1281‐7. ">Mori 2011</a>) investigated the effects of combination of iTBS and a programme of exercise therapy (summarised above under 'Physical activity programme' subheading). </p> <p>One trial (<a href="./references#CD009974-bbs2-0004" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , BoffaL , RimanoA , et al. Effects of Intermittent Theta Burst Stimulation on spasticity in patients with Multiple Sclerosis. European Journal of Neurology2010;17:295‐300. ">Mori 2010</a>) evaluated the effectiveness of two weeks of daily sessions of iTBS in people with MS with lower limb spasticity. Twenty participants were pseudo‐randomised to either real or sham iTBS protocol. The compound motor action potentials and H reflex amplitude ratio (a reliable neurophysiological index of spinal excitability) and the MAS for spasticity were evaluated by blinded raters before and after the stimulation protocols. Compared with the sham control group, there was a significant reduction in MAS score from baseline in the intervention group at both one week after stimulation (9.86 ± 3.13 versus 7.14 ± 4.03; P &lt; 0.05) and two weeks after the end of stimulation protocol (9.86 ± 3.13 versus 6.86 ± 3.20, P &lt; 0.05). Similarly, participants receiving real iTBS showed a significant reduction in compound motor action potentials and H reflex amplitude ratio (74.6% ± 0.15%, P &lt; 0.05 ) one week after the stimulation and persisting up to two weeks after the end of stimulation protocol (82.3% ± 0.22%, P &lt; 0.05). There were no significant effects for sham stimulation. </p> <p>One double‐blind placebo‐controlled study (<a href="./references#CD009974-bbs2-0006" title="NielsenJF , SinkjaerT , JakobsenJ . Treatment of spasticity with repetitive magnetic stimulation; a double‐blind placebo‐controlled study. Multiple Sclerosis1996;2(5):227‐32. ">Nielsen 1996</a>) evaluated the effect of rTMS on spasticity in 38 people with MS. Participants were given one session of 16 stimuli of 25Hz over the leg motor area and one session of five minutes rTMS twice daily for seven consecutive days. At day one post‐treatment: MAS score improved significantly in the treatment group compared with the control group (mean change ‐3.3 ± 4.7 AU versus 0.7 ± 2.5 AU, P = 0.003); self‐score of ease of daily day activities improved significantly in both groups (P &lt; 0.05 for both groups), but there was no difference between the groups. The threshold of the stretch reflex also increased significantly in the treatment group compared with the control group (4.3 ± 7.5deg/s versus ‐3.8 ± 9.7deg/s, P = 0.001). At day eight post‐treatment, there was no statistically significant difference in clinical spasticity score or self‐score of ease of daily day activities between the two groups, however, the threshold of the stretch reflex remained improved significantly in the treatment group compared to the control group (4.4 ± 7.5deg/s versus ‐1.8 ± 8.5deg/s, P = 0.028). At day 16 post‐treatment, none of the scores remained statistically significant between the two groups. </p> </section> <section id="CD009974-sec-0069"> <h4 class="title">Electromagnetic therapy</h4> <p>Two studies evaluated the effectiveness of electromagnetic therapy: one a pulsed electromagnetic therapy (<a href="./references#CD009974-bbs2-0002" title="LappinMS , LawrieFW , RichardsTL , KramerED . Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double‐blind, placebo controlled trial. Alternative Therapies in Health and Medicine2003;9:38‐48. ">Lappin 2003</a>); and one magnetic pulsing device (Enermed) (<a href="./references#CD009974-bbs2-0007" title="RichardsTL , LappinMS , Acosta‐UrquidiJ , KraftGH , HeideAC , LawrieFW , et al. Double‐blind study of pulsing magnetic field effects on multiple sclerosis. Journal of Alternative &amp; Complementary Medicine1997;3(1):21‐9. ">Richards 1997</a>). </p> <p>One multi‐site, double‐blind, placebo‐controlled, cross‐over trial (<a href="./references#CD009974-bbs2-0002" title="LappinMS , LawrieFW , RichardsTL , KramerED . Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double‐blind, placebo controlled trial. Alternative Therapies in Health and Medicine2003;9:38‐48. ">Lappin 2003</a>) evaluated the effects of a pulsed electromagnetic therapy on MS‐related fatigue, spasticity, bladder control, and overall QOL. This trial included 117 participants, who received four weeks of the active and placebo treatments separated by a two weeks washout period. There was significantly greater improvement in fatigue (P = 0.04) and QOL (P = 0.03) in the active device group compared with the control group. There were no significant differences in treatment effects for bladder control (P = 0.26) or disability composite (P = 0.77). The results for spasticity were mixed, indicating no significant difference in the treatment effects on daily diary ratings, however, muscle spasm/spasticity measured using the MSQLI measure at the end of each sessions showed statistically significant differences (P = 0.04). The three scales (fatigue, pain and spasticity) used to create the quality of life index (QLI) showed moderate inter‐correlations (r = 0.32 to 0.60). </p> <p>One double‐blind trial (<a href="./references#CD009974-bbs2-0007" title="RichardsTL , LappinMS , Acosta‐UrquidiJ , KraftGH , HeideAC , LawrieFW , et al. Double‐blind study of pulsing magnetic field effects on multiple sclerosis. Journal of Alternative &amp; Complementary Medicine1997;3(1):21‐9. ">Richards 1997</a>) evaluated clinical and subclinical effects of a magnetic pulsing device (Enermed) (with frequency of the magnetic pulse of 4‐13 Hz range) on disease activity in people with MS. Thirty people with MS randomly received either an active Enermed device (intervention group) or a similar magnetically inactive device (control group) on preselected sites between 10 and 24 hours a day for two months. There was a significant improvement in the performance scale (PS) combined rating for bladder control, cognitive function, fatigue level, mobility, spasticity, and vision in the treatment group compared with the control group (‐3.83 ± 1.08 versus ‐0.17 ± 1.07, change in PS scale, P &lt; 0.005). There was also a significant change between pre‐treatment and post‐treatment in alpha EEG magnitude during the language task. </p> </section> <section id="CD009974-sec-0070"> <h4 class="title">Transcutaneous Electrical Nerve Stimulation (TENS)</h4> <p>One single‐blind, cross‐over trial (<a href="./references#CD009974-bbs2-0003" title="MillerL , MattisonP , PaulL , WoodL . The effects of Transcutaneous Electrical Nerve Stimulation (TENS) on spasticity in Multiple Sclerosis. Multiple Sclerosis2007;13:527‐33. ">Miller 2007</a>), evaluated the effectiveness of TENS on spasticity in people with MS. Thirty‐two people with MS were randomly allocated into two groups: two weeks of 60 minutes (Group 1) and eight hours daily (Group 2) of TENS applications (100 Hz and 0.125 ms pulse width). There were no statistically significant differences in the Global Spasticity Score following either 60 minutes or eight hours daily of TENS (P = 0.433 and 0.217, respectively). However, compared to the short 60 minutes application, eight hours application time led to a significant reduction in muscle spasm (P = 0.038) and pain (P = 0.008). </p> </section> <section id="CD009974-sec-0071"> <h4 class="title">Vibration therapy</h4> <p>One trial (<a href="./references#CD009974-bbs2-0008" title="SchynsF , PaulL , FinlayK , FergusonC , NobleE . Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clinical Rehabilitation2009;23(9):771‐81. ">Schyns 2009</a>) evaluated the effectiveness of a Whole Body Vibration (WBV) programme on tone, muscle force, sensation and functional ability in MS. Sixteen participants were randomly allocated into two groups: Group 1 received four weeks of WBV plus exercise three times per week, two weeks of no intervention and then four weeks of exercise alone three times per week, while Group 2 received the two treatment interventions in the reverse order to Group 1. the exercise programme had positive effects on muscle force and well‐being, but there was insufficient evidence that the addition of WBV provided any further benefit. There was no difference in MAS score in either intervention. However, for each group, the combination of WBV and exercises showed significant reduction on MSSS‐88 sub‐scales of muscle spasms (P = 0.02) and pain (P = 0.036). No statistically significant changes were observed for other MSSS‐88 components (ADL, social functioning, stiffness, gait, body movement and emotional health). There were some improvements in functional abilities measured by 10‐metre walk and Timed Up and Go Test, which were statistically not significant (P = 0.56; P =0.70, respectively). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009974-sec-0072" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009974-sec-0072"></div> <p>A wide range of non pharmacological interventions are used for the treatment of spasticity in people with MS. The interventions investigated in this review include: physical activity programmes, magnetic stimulation therapies, electromagnetic therapies and vibration therapies. The studies generally were of poor quality design and were underpowered. There was 'low level' of evidence for non pharmacological interventions such as physical activities given in conjunction with other interventions (such as BoNT, iTBS); magnetic stimulation and electromagnetic therapies as beneficial for spasticity in people with MS. There was no evidence of benefit for the use of other non pharmacological interventions (such as TENS, sports climbing, vibration therapy) in treating spasticity in this population. </p> <section id="CD009974-sec-0073"> <h3 class="title" id="CD009974-sec-0073">Summary of main results</h3> <p>The nine included studies evaluated a range of non pharmacological interventions for treatment of spasticity in people with MS. The included trials were heterogeneous in terms of: type of intervention, outcome measures, and study quality. Hence, quantitative synthesis was not possible and a qualitative synthesis of 'best evidence' was provided. </p> <p>There is 'low level' evidence for:</p> <p> <ul id="CD009974-list-0035"> <li> <p>addition of active physiotherapy after BoNT injection in reducing spasticity up to 12 weeks; </p> </li> <li> <p>iTBS as a single intervention or in combination with exercise therapy reduced spasticity after two weeks of treatment; </p> </li> <li> <p>short‐term benefits of rTMS for improved spasticity, functional abilities and stretch reflex thresholds; </p> </li> <li> <p>short‐term beneficial effects of pulsing magnetic fields for spasticity, bladder control, cognitive function, fatigue level, mobility, and vision.  </p> </li> </ul> </p> <p>There is no evidence of benefit in the reported studies that TENS, sports climbing, and WBV (with or without an exercise programme) provide any additional improvements in spasticity in people with MS. </p> <p>The quality of evidence is reduced by the limited number of studies and the methodological weakness identified (underpowered, had high‐risk of bias with small sample size, short follow‐up periods, lack of rigorous methodology and variable use of outcome measures. Subgroup analysis for type of MS, disease severity (EDSS scores); disease duration and affected site i.e. upper limb, lower limb or both was not possible due to lack of data. </p> </section> <section id="CD009974-sec-0074"> <h3 class="title" id="CD009974-sec-0074">Overall completeness and applicability of evidence</h3> <p>Despite a wide search strategy only nine RCTs evaluating different forms of non‐pharmacological interventions were included. The three abstracts identified were not published as full studies and we were not able to get the further information from the primary authors. We are not aware of any other ongoing or unpublished studies. </p> <p>The included studies used a variety of outcome measures for spasticity, the most common being the MAS. These outcome measures are summarised in <a href="./references#CD009974-sec-0092" title="">Characteristics of included studies</a>. Due to the limited number of studies and quality of the existing studies, many aspects of non pharmacological interventions for MS spasticity remain unproven. This is consistent with the published guidelines for spasticity management (<a href="./references#CD009974-bbs2-0035" title="HaselkornJk , LittleJW , Balsdon RicherCB , MillerJR , Fry‐WelchD , HerndonRM , et al. Spasticity management in Multiple Sclerosis. Journal of Spinal Cord Medicine2005;28(2):167‐99. ">Haselkorn 2005</a>; <a href="./references#CD009974-bbs2-0053" title="MSAustralia . Spasticity and multiple sclerosis. MS Practice:June 2009; Vol. ISBN: 978‐0‐9806637‐4‐7. ">MS Australia 2009</a>) and a recent review of spasticity management in stroke population (<a href="./references#CD009974-bbs2-0030" title="DemetriosM , Turner‐StokesL , BrandC , McSweeneyS , KhanF . Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post‐stroke spasticity. Cochrane Database of Systematic Reviews2012, Issue 3. [DOI: 10.1002/14651858.CD009689] ">Demetrios 2012</a>). </p> <p>Studies where spasticity was measured incidentally; i.e. primary goal of the study was not to reduce spasticity, may have been missed or not reported. </p> </section> <section id="CD009974-sec-0075"> <h3 class="title" id="CD009974-sec-0075">Quality of the evidence</h3> <p>The nine included trials were rated as 'low' for methodological quality due to substantial flaws in their methodological design with a high risk of bias related to randomisation procedure, blinding protocols and outcome analysis. Further, all studies failed to give sufficient detail to assess their potential risk of bias in some areas of methodological quality domains, and correspondence was not received from the authors (<a href="#CD009974-fig-0002">Figure 2</a>). The limitations include: </p> <p> <ul id="CD009974-list-0036"> <li> <p>lack of reporting of definition of spasticity;</p> </li> <li> <p>high risk of selection bias as allocation concealment was described in only two studies (<a href="./references#CD009974-bbs2-0002" title="LappinMS , LawrieFW , RichardsTL , KramerED . Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double‐blind, placebo controlled trial. Alternative Therapies in Health and Medicine2003;9:38‐48. ">Lappin 2003</a>; <a href="./references#CD009974-bbs2-0007" title="RichardsTL , LappinMS , Acosta‐UrquidiJ , KraftGH , HeideAC , LawrieFW , et al. Double‐blind study of pulsing magnetic field effects on multiple sclerosis. Journal of Alternative &amp; Complementary Medicine1997;3(1):21‐9. ">Richards 1997</a>); </p> </li> <li> <p>lack of description of randomisation procedure, reported in only three studies (<a href="./references#CD009974-bbs2-0001" title="GiovannelliM , BorrielloG , CastriP , ProsperiniL , PozzilliC . Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clinical Rehabilitation2007;21(4):331‐7. ">Giovannelli 2007</a>; <a href="./references#CD009974-bbs2-0002" title="LappinMS , LawrieFW , RichardsTL , KramerED . Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double‐blind, placebo controlled trial. Alternative Therapies in Health and Medicine2003;9:38‐48. ">Lappin 2003</a>; <a href="./references#CD009974-bbs2-0008" title="SchynsF , PaulL , FinlayK , FergusonC , NobleE . Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clinical Rehabilitation2009;23(9):771‐81. ">Schyns 2009</a>); </p> </li> <li> <p>high risk of performance bias due to: non‐blinding of the study participants and treating personnel; described only in three studies (<a href="./references#CD009974-bbs2-0002" title="LappinMS , LawrieFW , RichardsTL , KramerED . Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double‐blind, placebo controlled trial. Alternative Therapies in Health and Medicine2003;9:38‐48. ">Lappin 2003</a>; <a href="./references#CD009974-bbs2-0006" title="NielsenJF , SinkjaerT , JakobsenJ . Treatment of spasticity with repetitive magnetic stimulation; a double‐blind placebo‐controlled study. Multiple Sclerosis1996;2(5):227‐32. ">Nielsen 1996</a>; <a href="./references#CD009974-bbs2-0007" title="RichardsTL , LappinMS , Acosta‐UrquidiJ , KraftGH , HeideAC , LawrieFW , et al. Double‐blind study of pulsing magnetic field effects on multiple sclerosis. Journal of Alternative &amp; Complementary Medicine1997;3(1):21‐9. ">Richards 1997</a>); only five studies took measures to blind outcome assessors (<a href="./references#CD009974-bbs2-0001" title="GiovannelliM , BorrielloG , CastriP , ProsperiniL , PozzilliC . Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clinical Rehabilitation2007;21(4):331‐7. ">Giovannelli 2007</a>; <a href="./references#CD009974-bbs2-0002" title="LappinMS , LawrieFW , RichardsTL , KramerED . Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double‐blind, placebo controlled trial. Alternative Therapies in Health and Medicine2003;9:38‐48. ">Lappin 2003</a>; <a href="./references#CD009974-bbs2-0004" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , BoffaL , RimanoA , et al. Effects of Intermittent Theta Burst Stimulation on spasticity in patients with Multiple Sclerosis. European Journal of Neurology2010;17:295‐300. ">Mori 2010</a>; <a href="./references#CD009974-bbs2-0007" title="RichardsTL , LappinMS , Acosta‐UrquidiJ , KraftGH , HeideAC , LawrieFW , et al. Double‐blind study of pulsing magnetic field effects on multiple sclerosis. Journal of Alternative &amp; Complementary Medicine1997;3(1):21‐9. ">Richards 1997</a>; <a href="./references#CD009974-bbs2-0008" title="SchynsF , PaulL , FinlayK , FergusonC , NobleE . Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clinical Rehabilitation2009;23(9):771‐81. ">Schyns 2009</a>); none of the studies attempted to test the success of patient blinding by questionnaire; </p> </li> <li> <p>most studies were underpowered with small sample sizes;</p> </li> <li> <p>generalisability of the results is limited, as most studies recruited participants from a single centre with strict inclusion and exclusion criteria; </p> </li> <li> <p>lack of an intention‐to‐treat analysis protocol;</p> </li> <li> <p>lack of longer‐term follow‐up to detect effect of intervention;</p> </li> <li> <p>difficulty controlling for patients' personal and other confounding factors, which influence patient‐therapist interaction, compliance, and delivery of therapy, thus impacting on outcomes, such as, patient motivation and self‐efficacy, comorbidity and activity level outside of therapy programmes, (not assessed in any of the studies). </p> </li> </ul> </p> </section> <section id="CD009974-sec-0076"> <h3 class="title" id="CD009974-sec-0076">Potential biases in the review process</h3> <p>The conclusions from this review are limited due to the small number of studies of poor methodological quality that investigated a range of non pharmacological interventions as described above. In addition, the review authors recognise a number of limitations in the methodology of the review itself, and the completeness of the retrieved literature. </p> <p> <ol id="CD009974-list-0037"> <li> <p>We were not able to rule out some degree of selection bias from the literature search (<a href="./references#CD009974-bbs2-0075" title="VanTulderMW , FurlanA , BombardierC , BouterL . Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group. Spine2003;28(12):1290‐9. ">Van Tulder 2003</a>), given that the search strategy principally encompassed the cited literature, despite the extended range of terms that were used to capture the widest possible selection of the relevant literature. </p> </li> <li> <p>We were not able to rule out publication bias as we cannot exclude the possibility that there have been negative trials that have not reached the published literature (<a href="./references#CD009974-bbs2-0031" title="EggerM , SmithGD . Bias in location and selection of studies. BMJ1998;316(7124):61‐6. ">Egger 1998</a>). </p> </li> <li> <p>Reference bias (<a href="./references#CD009974-bbs2-0032" title="GoetzschePC . Reference bias in reports of drug trials. British Medical Journal1987;295:654‐6. ">Goetzsche 1987</a>) is a further possible confounder, as our search strategy included searching of reference lists within the relevant papers for other possible articles missed in our electronic searches. </p> </li> </ol> </p> <p>We therefore welcome contact from any readers who are aware of important high quality studies that would meet the criteria for this review, but are so far not included. </p> </section> <section id="CD009974-sec-0077"> <h3 class="title" id="CD009974-sec-0077">Agreements and disagreements with other studies or reviews</h3> <p>The findings of this review highlight the existing gaps in literature and emphasise the importance, albeit finding some support for non pharmacological interventions for spasticity in MS. These findings are consistent with existing reviews for the management MS symptoms (<a href="./references#CD009974-bbs2-0024" title="BeardS , HunnA , WightJ . Treatments for spasticity and pain in multiple sclerosis: a systematic review. Health Technology Assessment2003;7:1‐111. ">Beard 2003</a>; <a href="./references#CD009974-bbs2-0065" title="RietbergMB , BrooksD , UitdehaagBMJ , KwakkelG . Exercise therapy for multiple sclerosis. Cochrane Database of Systematic Reviews2004, Issue 3. [DOI: 10.1002/14651858.CD003980.pub2] ">Rietberg 2007</a>; <a href="./references#CD009974-bbs2-0071" title="StevensonVL . Spasticity management. Clinical Rehabilitation2010;24:293‐304. ">Stevenson 2010</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009974-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/media/CDSR/CD009974/urn:x-wiley:14651858:media:CD009974:CD009974-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/media/CDSR/CD009974/image_t/tCD009974-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD009974-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009974.pub2/media/CDSR/CD009974/image_n/nCD009974-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/full#CD009974-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/media/CDSR/CD009974/image_n/nCD009974-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009974-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/media/CDSR/CD009974/urn:x-wiley:14651858:media:CD009974:CD009974-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/media/CDSR/CD009974/image_t/tCD009974-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009974-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009974.pub2/media/CDSR/CD009974/image_n/nCD009974-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/full#CD009974-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/media/CDSR/CD009974/image_n/nCD009974-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009974-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/media/CDSR/CD009974/urn:x-wiley:14651858:media:CD009974:CD009974-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/media/CDSR/CD009974/image_t/tCD009974-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009974-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009974.pub2/media/CDSR/CD009974/image_n/nCD009974-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/full#CD009974-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/media/CDSR/CD009974/image_n/nCD009974-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD009974-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Levels of quality of individual studies</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Judgement of risk of bias</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk of bias in all domains low</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High methodological quality = ‘high‐quality study’</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear or high risk of bias for one or more domains</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low methodological quality = ‘low‐quality study’</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk of bias for most domains</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low methodological quality = ‘very low‐quality study’</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Levels of quality of individual studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/full#CD009974-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009974-tbl-0002"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Levels of quality of a body of evidence in the GRADE approach  </span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Underlying methodology</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality rating</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised trials or double‐upgraded observational studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Downgraded randomised trials or upgraded observational studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Double‐downgraded randomised trials or observational studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Triple‐downgraded randomised trials or downgraded observational studies or case series/case reports </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Levels of quality of a body of evidence in the GRADE approach  </span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/full#CD009974-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009974-tbl-0003"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Summary of the findings</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Assessment points</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Summary of results</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Results – outcomes in favour of intervention group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Author’s conclusions</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009974-bbs2-0001" title="GiovannelliM , BorrielloG , CastriP , ProsperiniL , PozzilliC . Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clinical Rehabilitation2007;21(4):331‐7. ">Giovannelli 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline, and weeks 2, 4, and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD009974-list-0013"> <li> <p>Significant decrease in spasticity in treatment group compared to control group in MAS scores at weeks 2, 4, and 12, and in VAS rating scale at weeks 4 and 12 </p> </li> <li> <p>Control group MAS showed a transient decrease at week 2 and a slight increase at week 4 and week 12 </p> </li> </ul> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant decrease in MAS score in treatment group from baseline at (Mean (SD) change score): </p> <p> <ul id="CD009974-list-0014"> <li> <p>Week 2 : treatment group:‐0.91 (0.52) ; control group: ‐0.39 (0.50); P &lt; 0.01</p> </li> <li> <p>Week 4 : treatment group: ‐1.0 (0.69); control group ‐0.28 (0.46); P &lt; 0.01</p> </li> <li> <p>Week 12 : treatment group ‐0.95 (0.78); control group: ‐0.28 (0.46); P &lt; 0.01</p> </li> </ul> </p> <p>The mean (%) difference in MAS between baseline and the end of follow‐up was –0.95 (26.1) in the treatment group and –0.28 (7.7) in the control group (P &lt; 0.01). </p> <p> </p> <p>Significant improvement in spasticity in VAS rating scale (Mean (SD) change):</p> <p> <ul id="CD009974-list-0015"> <li> <p>Week 2 to week 4 : treatment group 1.77 (0.87) ; control group: 0 (1.08); P &lt; 0.01</p> </li> <li> <p>Week 4 to week 12: treatment group : 2.68 (1.08); control group: 1.06 (1.16); P &lt; 0.01 </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Addition of active physiotherapy after intramuscular botulin toxin increases reduction in spasticity even at 12 weeks. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009974-bbs2-0002" title="LappinMS , LawrieFW , RichardsTL , KramerED . Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double‐blind, placebo controlled trial. Alternative Therapies in Health and Medicine2003;9:38‐48. ">Lappin 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Before (baseline) and after 4 week treatment spell (week 4 and 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD009974-list-0016"> <li> <p>Significantly greater Improvement in fatigue and overall QOL in the active device compared with control group </p> </li> <li> <p>No significant differences in the treatment effects for bladder control (P = 0.26) (MSQLI) and disability composite (P = 0.77) (MSPS) </p> </li> <li> <p>Mixed result for spasticity: no significant difference in the treatment effects on daily diary ratings but MSQLI measure at the end of each sessions showed statistically significant differences (P = 0.04) </p> </li> <li> <p>The 3 scales (fatigue, pain and spasticity) used to create the QLI showed moderate inter‐correlations (r = 0.32 to 0.60), however, bladder control scale showed poor correlation with other MSQLI scales (r = 0.00 to 0.26) </p> </li> <li> <p>Adverse events: headaches, dizziness, numbness, fatigue, severe nausea</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean change scores between active vs. placebo groups::</p> <p> <ul id="CD009974-list-0017"> <li> <p>Bladder‐ 0.08 ; P = 0.26</p> </li> <li> <p>Spasms ‐ 0.13; P = 0.04</p> </li> <li> <p>Fatigue ‐0.14  ; P = 0.04</p> </li> <li> <p>3 item QOL ‐0.12; P = 0.03</p> </li> <li> <p>Disability level (8‐MSPS) – 0.12; P = 0.77</p> </li> </ul> </p> <p>No further data or analysis reported for spasms/spasticity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Although the clinical effects seen in the intervention group were small, exposure of people with MS to pulsing weak electromagnetic fields can alleviate some of their symptoms. </p> <p>More response on less severely disabled people.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009974-bbs2-0003" title="MillerL , MattisonP , PaulL , WoodL . The effects of Transcutaneous Electrical Nerve Stimulation (TENS) on spasticity in Multiple Sclerosis. Multiple Sclerosis2007;13:527‐33. ">Miller 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline and after (2 weeks) treatments; and follow‐up (8‐20 months) for the questionnaires for patient report for symptoms </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant differences in the Global Spasticity Score following either 60 minutes or 8 hours daily of TENS (P = 0.433 and 0.217 respectively) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD009974-list-0018"> <li> <p>8 hour TENS application time compared with the shorter 60 minute application time led to significant reduction in muscle spasm (P = 0.038) and pain (P = 0.008) </p> </li> <li> <p>At the end of the study (8‐20 months) patients reported reduction in symptoms: 87.5% for spasm, 73.3% for pain and 73.3% for stiffness </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TENS is not effective in reducing spasticity, but longer application time may be useful in treating pain and muscle spasm in people with MS. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009974-bbs2-0004" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , BoffaL , RimanoA , et al. Effects of Intermittent Theta Burst Stimulation on spasticity in patients with Multiple Sclerosis. European Journal of Neurology2010;17:295‐300. ">Mori 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline and after treatment (immediately after first sessions, 2 weeks) and follow‐up of each week up to 4 weeks post treatment) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Signiﬁcant reduction of H/M amplitude ratio and MAS  scores 1 week after the iTBS and persisting up to 2 weeks after  the  end  of  stimulation  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 weeks post iTBS treatment showed:</p> <p> <ul id="CD009974-list-0019"> <li> <p>Significant change in H/M amplitude ratio measured from the stimulated leg (P &lt; 0.01)</p> </li> <li> <p>Significant effect on MAS score measured from the stimulation target limb (P &lt; 0.001)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>iTBS is, a safe, non‐invasive, well‐tolerated and feasible protocol, and  a promising tool for the treatment of spasticity in MS. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009974-bbs2-0005" title="MoriF , LjokaC , MagniE , CodecaC , KusayanagiH , MonteleoneF , et al. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. Journal of Neurology2011;258(7):1281‐7. ">Mori 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline and after treatment (2 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD009974-list-0020"> <li> <p>Reduction in MAS, MSSS‐88, FSS scores, while in the Barthel index and MSQOL‐54, physical composite scores were increased, in iTBS and exercise group. </p> </li> <li> <p>·iTBS alone group showed a reduction of the MAS score.</p> </li> <li> <p>None of the measured scales showed significant changes in sham iTBS and exercise group</p> </li> </ul> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant improvement in the  iTBS and exercise group but not in the sham stimulation and exercise group in: </p> <p> <ul id="CD009974-list-0021"> <li> <p>MAS from the stimulated leg (2.1 ± 0.4 before treatment; 1.3 ± 0.4 after treatment; P &lt; 0.05) </p> </li> <li> <p>MSSS‐88 (74.3 ± 11.4 before treatment; 53.2 ± 10.9 after treatment; P &lt; 0.001)</p> </li> <li> <p>FSS (39.5 ± 4.2 before treatment; 31.6 ± 4.6 after treatment; P &lt; 0.05),</p> </li> <li> <p>Barthel index (92.5 ± 2.4 before treatment; 95.0 ± 1.85 after treatment; P &lt; 0.05)</p> </li> <li> <p>MSQOL‐54 physical health composite (59.7 ± 2.7 before treatment; 64.8 ± 2.7 after treatment; P &lt; 0.05) scores after treatment </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>iTBS associated with exercise therapy is a promising tool for motor rehabilitation of MS patients. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009974-bbs2-0006" title="NielsenJF , SinkjaerT , JakobsenJ . Treatment of spasticity with repetitive magnetic stimulation; a double‐blind placebo‐controlled study. Multiple Sclerosis1996;2(5):227‐32. ">Nielsen 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline  and after treatment (1 day, 8 days, and 16 days)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD009974-list-0022"> <li> <p>Significant improvement in clinical spasticity score (Ashworth Scale) in intervention group (rTMS) compared to control group </p> </li> <li> <p>Significant improvement in self‐score of ease of daily activities in both groups</p> </li> </ul> <ul id="CD009974-list-0023"> <li> <p>Significant improvement in stretch reflex thresh hold in both groups</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At day 1 post treatment:</p> <p> <ul id="CD009974-list-0024"> <li> <p>Ashworth Scale score for clinical spasticity improved significantly in treatment group compared to control group ( mean change ‐3.3 ± 4.7 AU vs. 0.7 ± 2.5 AU, P = 0.003) </p> </li> <li> <p>Self‐score of ease of daily day activities improved significantly in both groups (P &lt; 0.05 for both groups), but was no difference between the two groups. </p> </li> <li> <p>Threshold of the stretch reflex significantly increased in treatment group compared to control group (4.3±7.5 deg/s vs. ‐3.8 ± 9.7 deg/s, P = 0.001) </p> </li> </ul> </p> <p>At day 8 post treatment</p> <p> <ul id="CD009974-list-0025"> <li> <p>Threshold of the stretch reflex remain improved significantly in treatment group compared to control group (4.4 ± 7.5 deg/s vs. ‐1.8 ± 8.5 deg/s, P = 0.028) </p> </li> <li> <p>No statistically significant difference in clinical spasticity score or self‐score of ease of daily day activities between two groups </p> </li> </ul> </p> <p>At day 16 post treatment</p> <p> <ul id="CD009974-list-0026"> <li> <p>No statistically significant difference in any of the scores between two groups</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>rTMS has an short‐lasting antispastic effect in MS.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009974-bbs2-0007" title="RichardsTL , LappinMS , Acosta‐UrquidiJ , KraftGH , HeideAC , LawrieFW , et al. Double‐blind study of pulsing magnetic field effects on multiple sclerosis. Journal of Alternative &amp; Complementary Medicine1997;3(1):21‐9. ">Richards 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline  and after treatment (2 months)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD009974-list-0027"> <li> <p>No significant  change between  pre‐treatment  and  post‐treatment  in  the  EDSS  scale </p> </li> <li> <p>Significant  improvement in the performance  scale  (PS) combined  rating for bladder control, cognitive  function, fatigue  level,  mobility,  spasticity,  and vision  </p> </li> <li> <p>Significant  change  between  pre‐treatment  and  post‐treatment  in  alpha  EEG magnitude  during  the language  task </p> </li> <li> <p>Adverse events: headache, psychological problems, dizziness, increase spasm, skin irritation, nausea, exacerbation of MS </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant difference between pre‐treatment and post treatment within the treatment group in (mean (SD): </p> <p> <ul id="CD009974-list-0028"> <li> <p>Spasticity:  ‐0.80 (0.23); P &lt; 0.005</p> </li> <li> <p>Bladder control: ‐0.5 (0.23); P &lt; 0.05</p> </li> <li> <p>Cognition: ‐0.63 (0.37); P &lt; 0.05</p> </li> <li> <p>Fatigue: ‐0.87 (0.4); P &lt; 0.05</p> </li> <li> <p>Mobility: ‐0.4 (0.27); P &lt; 0.05</p> </li> <li> <p>Vision: ‐0.23 (0.21); P &lt; 0.05</p> </li> </ul> </p> <p>No adverse events: 6 in treatment group, 7 in control group.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Beneficial effect  of pulsing magnetic fields on MS patients treated  for a  period of 2 months, which is far too short to assess its effects  on the long‐term progression of MS. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009974-bbs2-0008" title="SchynsF , PaulL , FinlayK , FergusonC , NobleE . Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clinical Rehabilitation2009;23(9):771‐81. ">Schyns 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline  and after treatment (4 weeks) twice with 2 weeks cool‐off period (final at 12 weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD009974-list-0029"> <li> <p>Exercise programme had positive effects on muscle force and well being</p> </li> <li> <p>Insufficient evidence that the addition of WBV provided any further benefit</p> </li> <li> <p>No change in MAS scores for either intervention,</p> </li> <li> <p>MSSS‐88 showed whole body vibration and exercises reduced muscle spasms in both groups (P = 0.02) </p> </li> <li> <p>10‐m walk and Timed Up and Go Test improved, but was not statistically significant</p> </li> <li> <p>No effects on sensation</p> </li> <li> <p>Adverse event: exacerbate a pre‐existing knee condition (N = 1)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD009974-list-0030"> <li> <p>Tone tended to increase more for exercise alone compared with whole body vibration and exercise </p> </li> <li> <p>MSSS‐88 pain: statistically significant difference between the results before and after whole body vibration in treatment group (P = 0.036) and no significant difference for control group </p> </li> <li> <p>MSSS‐88 spasm: greater reduction in score was achieved using whole body vibration and exercise compared to exercise alone (P = 0.02, 95% CI = 2.00, 14.50) </p> </li> <li> <p>No statistically significant changes for other MSSS‐88 components (ADL, social functioning, stiffness, gait, body movement and emotional health) </p> </li> <li> <p>10‐m walk time: both interventions increased the subjects’ walking speed , however the difference between performance with vibration and exercise, and exercise alone was not statistically significant (P = 0.561). A similar pattern was observed with the results of the Timed Up and Go Test (P = 0.720) </p> </li> <li> <p>MSIS‐29: overall well being improved in both groups, however, there was no statistically significant difference between groups </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise may be beneficial to those with MS, but there is limited evidence that the addition of WBV provides any additional improvements. </p> <p>Exercise performed three times a week for four weeks <br/> improved muscle force output, functional ability and general well‐being in people with MS and addition of whole body vibration to the exercise programme provided some added benefit to exercise alone in terms of reducing muscle spasm. </p> <p>In addition there was a trend towards a greater increase in muscle force generation with the addition of WBV. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009974-bbs2-0009" title="VelikonjaO , CuricK , OzuraA , JazbecSS . Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis. Clinical Neurology &amp; Neurosurgery2010;112(7):597‐601. ">Velkonja 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline  and after treatment (10 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD009974-list-0031"> <li> <p>No significant improvements in spasticity after both interventions (sports climbing (SC) or yoga) </p> </li> <li> <p>Significant reduction in fatigue in SC group, while yoga had no effect</p> </li> <li> <p>No differences in executive function</p> </li> <li> <p>No significant impact of SC and yoga on mood.</p> </li> <li> <p>Increase in selective attention performance in the yoga group (17% increase; baseline: 151.0 (94.5–175.5); after: 176.5 (116.5–191.3; P = 0.005). </p> </li> </ul> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD009974-list-0032"> <li> <p>SC group had 25% reduction (P = 0.046) in EDSSpyr; before  4.0 (3.0–4.0) after 3.0 (2.5–4.0) </p> </li> <li> <p>SC reduced fatigue for 32.5% (P = 0.015)</p> </li> <li> <p>Significant effect of SC on the level of fatigue (P = 0.015) as evaluated with the MFIS </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yoga and SC might improve some of the MS symptoms and should be considered in the future as possible complementary treatments. </p> <p> </p> <p>Unable to prove that SC and yoga have an effect on spasticity or mood in patients with MS. SC did not significantly affect performance on tests of selective attention and executive functions, while in the yoga group there was an improvement in selective attention performance and no effect on executive functions. There was a decrease in the level of everyday fatigue in patients with SC but not in the yoga group. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>ADL = activities of daily living; BoNT = botulinum toxin type A; EDSS = Expanded Disability Status Scale; EDSSpyr = EDSS pyramidal functions score; FSS = Fatigue Severity Scale; HRQOL = health‐related quality of life; iTBS = Intermittent Theta Burst Stimulation; MAS = Modified Ashworth Scale; MFIS = Modified Fatigue Impact Scale; MS = Multiple Sclerosis; MSQLI = MS Quality of Life Inventory; MSIS‐29 = Multiple Sclerosis Impact Scale; MSSS‐88 = Multiple Sclerosis Spasticity Scale; MSPS = MS Performance Scale; QLI = quality of life index; QOL = quality of life; SC = Sports climbing; SD = standard deviation; TENS = Transcutaneous Electric Nerve Stimulation; rTMS = Repetitive Transcranial Magnetic Stimulation; VAS = Visual Analogue Scale; WBV = Whole Body Vibration </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Summary of the findings</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009974.pub2/full#CD009974-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009974.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD009974-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD009974-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009974-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009974-note-0002">Français</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009974\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009974\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009974\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009974\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009974\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009974\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009974\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009974\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009974\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009974\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009974\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009974\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009974\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009974\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009974\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009974\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009974\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009974\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xNbeAU8n&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009974.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009974.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009974.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009974.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009974.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716762973"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009974.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716762977"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009974.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918da7723fcd1be3',t:'MTc0MDcxNjc2My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 